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ABREVIATIONS 
ACC1: Acetyl-CoA Carboxylase 
AI: Atriplex infalata 
AlCl3 6H2O: Aluminum chloride hexahydrate solution 
AS: Arthrophytum scoparium 
BW: Body weight 
c-DNA: Complementary DNA 
CE: Catechin equivalents 
CEBP- α: CCAAT/enhancer-binding protein alpha 
CHFD: Control High-fat diet fed group 
CND: Control Normal diet fed group 
CPT1: Carnitine palmitoyl-transferase I 
DAD: Diode array detector 
DMEM: Dulbecco’s modified Eagle’s medium 
DNA: Deoxyribonucleic acid 
DPPH: 2,2-Diphenyl-1-picrylhydrazyl  
Db/db mice: Diabetic mice 
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EC50 (μg/mL): Effective concentration, at which the absorbance was 0.5 
FAS: Fatty acid synthase 
FBS: Fetal bovine serum 
Fe 
3+
: Denoted Iron (III)  
FeCl3: Iron (III) chloride anhydrous 
FRAP: Ferric reducing antioxidant power  
GAE: Gallic acid equivalents 
HCl: Hydrochloric acid, 
HDL: High-density lipoprotein 
HDL-c: High-density lipoprotein cholesterol  
HFD: High-fat diet 
HFD+PC: High-fat diet + positive control (Naringenin 10 mg/kg body weight) 
HFD+NR50: High-fat diet + Nitraria retusa 50 mg/kg body weight 
HFD+NR100: High-fat diet+ Nitraria retusa 100 mg/kg body weight 
HPLC: High performance liquid chromatography 
IC50 (μg/mL): Inhibiting concentration of 50% of the synthetic radical DPPH  
Iso: Isorhamnetin 
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K3Fe (CN) 6: Potassium ferricyanide (III) 
LDL: Low-density lipoprotein 
LDL-c: Low-density lipoprotein cholesterol 
LPL: Lipoprotein lipase 
ME: Mesembryanthemum edule 
mg CE g/ DW: Milligram catechin equivalent per gram dry weight  
mg GAE g/ DW: Milligram gallic acid equivalent per gram dry weight 
mRNA: Messenger Ribonucleic acid 
MTT: 3-(4 5-dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide 
Na2CO3: Sodium carbonate anhydrous  
NaNO2: Sodium nitrite 
NaOH: Sodium hydroxide  
ND: normal diet 
NR: Nitraria retusa  
NRE: Nitraria retusa ethanolic extract 
PCR: The polymerase chain reaction  
PPAR-α: Peroxisome proliferator-activated receptor alpha 
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PPAR- γ: Peroxisome proliferator-activated receptor gamma 
RP: Reverse phase  
RP-HPLC: Reverse phase high performanceliquid chromatography  
RS: Rantherium sueavelons  
SDS: Sodium dodecyl sulfate 
SREBP-1c: Sterol Regulatory Element-Binding Protein-1-c 
TAA: Total antioxidant activity 
TCA: Trichloroacetic acid 
TCHO: Total cholesterol  
TEAC: Trolox equivalent antioxidant capacity  
TG: Tamarix gallica or triglycerides 
TMA: Total monomeric anthocyanins 
TNF-α: Tumor necrosis-factor-alpha 
TP: Total phenolics 
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WHO: World health organization 
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CHAPTER 1 
 
General introduction 
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1.1. Definition of obesity 
 
According to WHO, obesity can be defined as an excess of body fat relative to lean body mass. 
A human subject is considered obese if they have a body mass index (BMI) of 30 and above. 
However, term of obesity is not limiting and depends on cultural and social definitions (Font et 
al., 2010). By 2005, obesity had affected 400 million adult, and since 1997, WHO has cited 
obesity as a global epidemic (Kazemipoor et al., 2012). At the cell biological level, obesity is 
characterized by an increase in the number (Hyperplasia) and size (Hypertrophy) of adipocytes. 
A lean adult has adult 35 billion adipocytes, each containing about 0.4 to 0.6 µg of triglycerides; 
an extremely obese adult can have four times as many adipocytes (125 billion), each containing 
twice as much lipid (0.8-1.2 µg of triglyceride) (Hirsch et al., 1970). Many reports defined 
obesity as a medical and physical condition that results from excessive storage of fat in the 
body, and, characterized by the accumulation of fat to the extent that it may induce side effects 
on health, leading to reduced life expectancy and/or increased health problems (Kazemipoor et 
al., 2012; Haslam and James, 2005). Therefore, over consumption of calories and decreased 
energetic activity could be the major cause of obesity. Losing weight became a big interest to 
have major health benefits for overweight people and also enhances life expectancy in people 
having obesity-related disorders (Rayalam et al., 2008). The main treatment for obesity consists 
of dieting and physical exercise (Lau et al., 2007). Diet programs may produce weight loss over 
the short term (Sacks et al., 2009), but keeping this weight loss is often difficult requiring a 
lower and enduring food energy diet. Therefore managing obesity and maintaining optimum 
body weight through an alternative therapy could help and be a vital part to manage life style 
disorders and related metabolic syndrome disease. 
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1.2. Obesity and adipogenesis  
 
Obesity is produced due to an imbalance between energy intake and energy expenditure that 
finally leads to the uncontrolled growth of fat cells called adipocytes (Song et al., 2013). 
Adipocytes accumulate lipids through adipogenesis in adipose tissue, and adipogenesis is the 
process by which undifferentiated precursor cells (fibroblast-like-pre-adipocytes) differentiate 
into fat storage cells or mature cells called adipocytes (Fruhbeck et al., 2001). The conversion 
from undifferentiated fibroblast-like pre-adipocytes into complete adipocytes constitutes the 
adipocyte life cycle (Rayalam et al., 2008). Thus, a dramatic increase in the rate of obesity is a 
result of an excessive accumulation in white adipose tissue. Numerous studies have 
demonstrated that adipocyte differentiation and the amount of fat accumulation as well as 
adipocyte dysfunction are strongly associated with development of obesity, which is a major risk 
factor for many disorders including diabetes, hypertension, and cardio-vascular disease (Lee et 
al., 2009). 
1.3. Obesity and related-metabolic disorders 
1.3.1. Western-style diet (High-fat diet) and metabolic syndrome diseases 
Generally, life styles are associated to increasing occurrences of overweight and risks of obesity 
related-diseases. The etiology of obesity is complex, dietary factors, particularly the feeding of a 
high-fat (HF) diet is supposed to be one of the central factors for its development (Woods et al., 
2003). To date, progresses in the understanding of energy metabolism have revealed many of the 
regulatory systems involved in the homeostasis of body weight. Consuming high fat diets 
regularly may lead to an increasing of fat storage (Astrup, 1993; Woods et al., 2003). Therefore, 
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epidemiological studies have recognized a positive correlation between mean dietary fat intake 
and the incidence of obesity and its related health disorders and risk factors (Lichtenstein, 1998). 
The incidence of metabolic syndrome rises with the severity of obesity and touches 50% in 
morbidly obese youngsters (Lee, 2013). Obesity is considered as the most crucial predisposing 
factor for insulin resistance, resulting in high levels of glycemia and insulinemia which finally 
induce the development of diabetes (Shulman, 2000). In addition metabolic syndrome may lead 
to the chronic inflammatory state and metabolic disorders that predisposes on the other health 
problems mainly related to cardiovascular diseases, such as, hypertension, lipoprotein 
abnormalities and atherosclerosis (Wahba and Mak, 2007). Consequently, the increased 
prevalence of obesity and obesity-associated complications continues to be a foremost global 
health concern. This is due mainly to the cause of obesity that is multifactorial.  
1.4. Proposed mechanisms for prevention and treatment of obesity (in vitro and in vivo 
models): 
Several reports have outlined the mechanisms of proposed anti-obesity including decreased 
energy intake and increased energy expenditure (in vivo studies), decreased pre-adipocyte 
differentiation and proliferation, decreased lipogenesis and increased lipolysis, and fat oxidation 
(in vitro and in vivo studies) (Manchini et al., 2001). 
1.4.1. Obesity studies using in vitro models:  
-3T3-L1 cell line     
Many models and techniques are being used in order to evaluate and understand adipocyte 
biology. 3T3-L1 is a pre-adipose and not cancer cell line, which was generated from clonal 
expansion of murine Swiss 3T3 cells and contains only a single cell type. This cell line is one of 
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the best-characterized and reliable models for studying the conversion of pre-adipocytes into 
adipocytes (Zhou and Zhu, 2009). Reports have outlined the mechanisms of proposed ant-
obesity. Among them, pre-adipocytes play a key role in increased fat mass through increased 
number and size of adipocytes leading to the differentiation into mature adipocytes. Thus, both 
suppression of pre-adipocyte differentiation and decrease in cell viability of pre-adipocytes as 
well as adipocytes are potential means to manage and treat obesity (Wang and Jones, 2004; Lii et 
al., 2011). Moreover, many research studies used 3T3-L1 cells to identify key molecular markers 
and related pathways of pre-adipocyte differentiation. The cell differentiation is a multi-stage 
process involving synchronized regulation of specific genes and proteins expression linked with 
each phase of adipogenesis (Ntambi and Young-Cheul, 2000). Adipogenic transcriptions factors 
such as of the CCAAT/enhacer binding protein-beta (C/EBP-β), nuclear receptor peroxisome 
proliferator-activated receptor gamma (PPAR-γ), and CCAAT/enhacer binding protein-alpha 
(CEBP-α) play a key role in the complex transcriptional cascade that occurs during adipogeneis 
(Cristancho and Lazar, 2011). Therefore, understanding the mechanism through which a 
determined compound or mixture of compounds affect the differentiation to adipocytes would be 
one of the approaches which lead to reduce or prevent the onset and progression of obesity.  
-Chronological changes and transcriptional cascade during adipocyte differentiation 
Adipocyte differentiation is known to be mediated by cell cycle and differentiation factors and 
controlled by diverse signaling events which could inhibit or stimulate the adipogenesis process. 
This process involves two main phases the recruitment and proliferation of adipocyte precursor 
cells called pre-adipocytes, followed by their differentiation into mature fat cells. The maturation 
step is characterized by the alteration of cell shape, growth arrest and clonal expansion. 
Consequently, a sequence of specific changes in gene expression related to lipid storage occurs 
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(Gregoire, 2001). Interaction among the members of C/EBP and PPAR families play a crucial 
role during adipogenesis process. CCAAt/enhancer binding protein-beta (CEBP-β) is expressed 
immediately after the induction of differentiation, and then PPAR-γ and CCAAt/enhancer binding 
protein-alpha (CEBP-α) act synergistically to maintain their high levels and promote 
adipogenesis (Rayalam et al., 2007). They activate in coordinated functions, the expression of 
their target genes; adipocyte-specific genes; such as adipocyte fatty acid-binding protein (aP2), 
lipoprotein lipase (LPL), leptin, adiponectin, glucose transporter-4 and fatty acid synthase (FAS). 
This cooperative regulation leads to morphological changes and fat accumulation within cells 
(Takahashi et al., 2009). 
1.4.2. Obesity studies using in vivo models:  
Obesity is associated with several health problems, including diabetes, cardiovascular disease, 
respiratory failure, muscle weakness and cancer (Kanasaki and Koya, 2011). To better 
understand the pathological mechanisms of human disease, good animal models are essential. 
Thus, many rodent models of obesity are used in the research of obesity-related human health 
conditions and diseases such as diabetes and cancer. 
1.4.2.1. Monogenic mice obesity models: 
In rodents, a number of autosomal recessive gene mutations that result in the obese phenotype 
have been described, including ob/ob and db/db mice (Zhang et al., 1994; Tartaglia et al., 1995). 
In 1949, researchers from the Jackson laboratory discovered obese mice. The db/db mouse was 
identified initially in 1966 by researchers in the Jackson Laboratory as an obese mouse 
(Kanazaki and Koya, 2011). It was also reported that, the products of the ob and db genes 
represent a hormone-receptor pair (leptin, produced and released into the plasma by adipocytes, 
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and its receptor, present in hypothalamic nuclei, respectively) that acts as a component of a 
negative feedback system involved in the regulation of fat mass (Lin et al., 2000). Impaired 
leptin signaling in the hypothalamus of ob/ob mice (unable to produce leptin) and db/db mice 
(unable to respond to leptin) leads to persistent hyperphagia, and obesity. Other metabolic 
abnormalities could occur such as hyperlipidemia, insulin resistance, decreased energy 
expenditure and diabetes (Chen et al., 1996; Pelleymounter et al., 1995). 
-Monogenic mice model used in this study: db/db mice 
Strain Name: BKS.Cg-Dock7m +/+ Lepr 
db
/J: Congenic; Mutant Strain. 
Appearance 
-Leprdb: black, fat 
Related Genotype: a/a + Leprdb/+ Lepr
db
 
-Dock7m Leprdb: black, lean 
Related Genotype: a/a Dock7m +/+ Lepr
db
 
-Dock7m: misty (grey), lean 
Related Genotype: a/a Dock7m +/Dock7m + 
Mice homozygous for the diabetes spontaneous mutation (Lepr
db
) become identifiably obese 
around three to four weeks of age. Elevations of plasma insulin begin at 10 to 14 days of age and 
of blood sugar at four to eight weeks. Homozygous mutant mice are polyphagic, polydipsic, and 
polyuric (http://www.renasci.co.uk/experimental/obesity/dietary-induced-obese-animals).  
At one month of age, db/db mice are larger (obese) when compared to control (heterozygous) 
littermates, and db/db mice present increased fat deposition in the inguinal and axillary regions. 
They also develop frank hyperglycemia by 8 weeks of age (Lee et al., 1996). Consequently these 
mice are widely used as a model for the study of obesity and type-2- diabetes. 
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1.4.2.2. Diet-induced obese mice model: 
Dietary-induced obese (DIO) mice and rats are well-established animal models of obesity. A 
high-fat diet (HFD) is often utilized in obesity research as a non leptin-deficient model. There are 
mouse strain-specific differences in responses to the HFD (West et al., 1992). C57BL/6J mice 
are the most widely used for HFD-induced obesity because they display aberrations similar to 
human metabolic syndrome when fed the HFD (Kanasaki and Koya, 2011). There are major 
differences among sub-strains in response to the HFD. For example, while C57BL/6J mice 
exhibit HFD-induced obesity, hyperinsulinemia, and insulin resistances that nearly parallel the 
progression of human disease; C57BL/KsJ mice exhibit a weak phenotype (Kanasaki and Koya, 
2011). 
-Diet-induced obese mice model used in this study  
-Strain Name: C57B6J/L 
Common Names: C57 Black;     B6;     B6J;     Black 6; 
Appearance:  black; Related Genotype: a/a 
C57BL/6J is the most widely used inbred strain and the first to have its genome sequenced. Even 
though this strain is refractory to many tumors, it is a permissive background for maximal 
expression of most mutations (Buettner et al., 2007). They are predisposed to diet-induced 
obesity, type 2-diabetes, and atherosclerosis (Buettner et al., 2007). C57BL/6J mice fed a high-
fat diet develop obesity, mild to moderate hyperglycemia, and hyperinsulinemia. Obesity is 
induced in male C57BL/6J mice by allowing them unlimited access to high fat diet supplying 
either 45% or 60% energy (JAX® Diet-induced Obesity (DIO) Models). Studies in dietary-
induced obese mice are popular as an initial screen as they require fewer compounds than 
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dietary-induced obese rats and are easily to perform as mice are given their food as a single-
source (Kanasaki and Koya, 2011). In conclusion, using such high-fat diet-induced obesity mice 
models could be one of alternatives to fight against human obesity. 
 
1.5. Role of traditional medicinal plants and their bioactive compounds in the management 
and treatment of obesity: an overview 
Medicinal plants and plant extracts represent the ancient and most prevalent form of medication.  
The use of natural therapies for weight loss has enlarged, based on consistency, safety, and cost 
compared with artificial drugs or surgical procedures, which may have limitations (Calixto, 
2000). A large group of literature indicates that considerable progress has been made relating to 
our knowledge of bioactive components in plant foods and their links to obesity. Therefore, a 
sum of studies have been carried out to investigate the anti-obesity effects of polyphenols like 
apigenin and luteolin (Han et al., 2003), kaempferol (Yu et al., 2006), genistein and diadzein 
(Kim et al., 2006; Dang and Lowik, 2004), grape seed proanthocyanidin extract (GSPE) (Preuss 
et al., 2000), and epigallocatechin gallate (EGCG) (Wolfram et al., 2006). In other hand, certain 
animal studies reported the efficiency of some known herbs and vegetables lowering overweight 
and related disorders caused by obesity. The most known are, Foeniculum vulgare miller 
(Fennel), Camellia sinesis (Tea), Trigonella foenum graecum (Fenugreek) and Ceratonia siliqua 
(Locust bean) which act in different ways (Kazemipoor et al., 2012). In same respect and based 
on a number of in vivo studies regarding the efficacy of anti-obesity medicinal plant 
preparations, they may act by stimulating thermogenesis, reducing lipogenesis, increasing 
lipolysis through inducing β-oxidation (Okuda et al., 2001), suppressing appetite, and decreasing 
lipid absorption (Kazemipoor et al., 2012). Other medicinal plants have been repoted for their 
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effect to inhibit adipocyte differentiation and fat cell formation (Van heerden and Gordonii, 
2008). 
 
1.6. Potential of halophytes as medicinal plants 
Plants having the ability to grow and complete their life cycle in habitats with a high salt content 
are called salt plants or halophytes. Halophytes have particular characteristics allowing them to 
evade and/or resist and tolerate salinity in arid regions as well as in humid regions (Abdelly et al., 
2011). Eco-physiological studies on halophytes in arid lands shows that these plants are endowed 
with particular mechanisms and adaptations which enable them to survive, grow and reproduce, 
or even survive without net growth under the extreme conditions (severe drought and salinity) 
prevailing in arid zones (Khan et al., 2006). 
Salt resistance can include either salt tolerance strategy or salt avoidance strategy:  
-Salt tolerance involves physiological and biochemical adaptations for maintaining 
protoplasmic viability as cells accumulate electrolytes. 
-Salt avoidance implicates structural with physiological adaptations to reduce salt 
concentrations of the cells or physiological excretion by root membranes. 
Halophytes are frequently classified as excretive or (exclusive) and succulents (inclusive): 
-Excretive halophytes possess gland cells capable of secreting excess salts from plant 
organs. 
-Succulents have high water content within large vacuoles to minimize salt toxicity (Foyer and 
Noctor, 2005).  
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According to Ben Hamed et al., (2013) halophytes are distinguished from glycophytes mainly by 
their growth response to salinity. Comparative studies between halophytes and glycophytes 
have shown that halophytes are better equipped with the mechanisms of cross-stress tolerance 
and are constitutively prepared for stress. Halophytes existing in the extreme environments 
have to deal with numerous changes in salinity level. These species are known for their ability 
to endure and quench toxic Reactive Oxygen Species (ROS), since they are equipped with a 
powerful antioxidant system (Ksouri et al., 2009). At present, an increasing interest is granted 
to these species because of their high content in bioactive compounds (primary and secondary 
metabolites) such as vitamins, sterols, essential oils (terpenes), polysaccharides, glycosides, and 
phenolic compounds (Ksouri et al., 2011). In Tunisia, there is a large diversity of halophytic 
plants of multiple interests including therapeutic practices, economic and agro-alimentary 
applications.  
1.7. Plant material used in anti-obesity study:    
In current study, six halophytes samples were selected, based on the screening results as well as 
on the scientific reports related to their biological activities and their chemical composition.  
1.7.1. Botanical description and geographical distribution: 
-Nitraria retusa (Forssk) is a salt shrub or bush in the Nitrariaceae family. It is known locally as 
Al-Ghardaq and described as a perennial and spiny plant. The plant grows to 2.5 m tall, although 
it is usually less than 1 m in height. It has tiny, white to green, fragrant flowers, and small edible 
red fruits (Hadj Salem et al., 2011). The plant is native to desert areas and saline soils of northern 
Africa, where it grows in primary succession on barren sand dunes (Suleiman et al., 2008). 
  Order: Sapindales 
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Family: Nitrariaceae 
Genus: Nitraria 
Species: retusa 
- Tamarix gallica (L.), or French Tamarisk, is a deciduous, herbaceous, shrub or small tree 
reaching up to about 5 meters high. It is native in Saudi Arabia and the Sinai Peninsula, and very 
common around the Mediterranean region (Lawrence, 1985). Tamarix gallica is a tree or shrub 
halophyte widespread in coastal regions and desert, relatively long-living plant that can tolerate a 
wide range of environmental conditions and resist abiotic stresses such as salt, high luminosity, 
and drought stresses (Saïdana et al., 2007). 
Order: Caryophyllales 
Family: Tamaricaceae 
Genus: Tamarix 
Species: gallica 
  
-Mesembryanthemum edule (L.) or (Carpobrotus edulis), is succulent plant adapted to arid 
conditions and characterized by fleshy water-storing tissues that act as water reservoirs, having a 
capsular fruit containing edible pulp (Watson, 2007). It is an invasive species adapted to many 
regions throughout the world, notably Australia, California and the Mediterranean having similar 
climates (Van Der Watt and Pretorius, 2001). On the Mediterranean coast, Messembryanthemum 
edule has extent rapidly and many parts of the coastline are fully covered by this invasive 
species. 
Order: Caryophyllales 
Family: Aizoaceae 
13 
 
Genus: Mesembryanthemum 
Species: edule 
-Atriplex inflata or Atriplex lampifer (Muell.) 
Atriplex is a plant genus of 250-300 species, known by the common names of saltbush 
distributed closely worldwide from subtropical to temperate and to subarctic regions (Mavrodiev 
et al., 2010). The species in genus Atriplex are annual or perennial herbs, subshrubs, or shrubs 
(Welsh, 2003). Atriplex inflata is saltbush, found around salt flats and low salinized area. It is an 
annual Chenopodiaceae species that reaches a height of about 50 cm. It has simple leaves that are 
alternate. It mostly exist in saline habitats, namely in arid regions. This species is introduced in 
many regions in the world for its great forage value (Atia et al., 2011). 
Order: Caryophyllales 
Family: Chenopodiaceae 
Genus: Atriplex 
Species: inflata 
 -Arthrophytum scoparium or Hammada scoparia (POMEL) 
Arthrophytum scoparium or Hammada scoparia belonging to Chenopodiaceae family,  is a 
small, highly branched halophytic shrub that are widely distributed in south-east Spain, North 
Africa, and parts of Iran, Turkey, Iraq and Syria (Irano-Turanian region) (A guide to medicinal 
plants in North Africa, 2005). This plant grows wild in dry habitats of the Mediterranean region 
and the Near East (Maire, 1962; Ben Salah et al., 2002). 
 
Order Caryophyllales 
Family Amaranthaceae 
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Genus: Arthrophytum  
Species: Scoparium 
 
-Rhanterium suaveolens 
Rantherium suaveolens (Desf), endemic North African species locally known as Arfej, is a 
perennial weedy shrub widely distributed in the northern Sahara in the extreme south of Tunisia 
(Issaoui et al., 1996). 
Order: Asterales  
Family: Asteraceae  
Genus: Rhanterium 
Species: suaveolens 
 
1.7.2. Traditional uses, biological activities and chemical composition: 
-Nitraria retusa Forssk. Asch. 
This plant is used in traditional medicine in Tunisia and Egypt. The dry leaves are used in 
decoction as a substitute to tea and to make cataplasms. Ashes of this plant have the anti-
inflamatory property treating the infected wounds. Its fleshy red fruits are eaten by human beings 
and birds; its wood is used as fuel by the local inhabitants (Hadj Salem et al., 2011). In a 
previous chemo-systematic investigation of  leaves and young stems of N. retusa, Halim et al, 
(1995), isolated and fully characterized six flavonol glycosides: isorhamnetin-3-O-4-
rhamgalactosyl-robinobioside, isorhamnetin-3-O-robinobioside, isorhamnetin-3-O-rutinoside, 
isorhamnetin-3-O-galactoside, isorhamnetin-3-O-glucoside, and, free isorhamnetin. These 
bioactives molecules isolated from Nitraria retusa have been reported to promote apoptosis in 
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human myelogenous erythroleukemia cells (Boubaker et al., 2012), and to exert anti-oxidant and 
anti-mutagenic activities (Boubaker et al., 2010). 
 
-Tamarix gallica L. 
Tamarix spp. was employed in traditional medicine as astringent, aperitif, diuretic (Saïdana et al., 
2007), active against leucoderma, spleen trouble and eye diseases (Sharma and Parmar, 1998). 
Younos et al. (2005) indicate the importance of this genus in some old civilizations and the 
actual uses of the different parts (leaves, flowers, and galls) of Tamarix species in the traditional 
Asian therapy (anti-inflammatory, anti-diarrheic, cicatrizing agent, and antiseptic) in relation to 
their chemical composition, mainly constituted by polyphenols. The extract of Tamarix gallica is 
very rich in acid compounds such as; Gallic, sinapic, chlorogenic, syringic, vanillic, p-coumaric, 
and trans-cinnamic acids. As well as in flavonoids: (+)-catechin, isoquercetin, quercetin, 
apigenin, amentoflavone, and flavones and Tannins.  The presence of these compounds exhibit a 
wide spectrum of medicinal properties, such as; anti-allergic, anti-inflammatory, cardio-
protective and vasodilatory effects (Ksouri et al., 2009). 
-Mesembryanthemum edule L. 
Leaves of   Mesembryanthemum edule are edible as are its fruit. Reports have shown that genus 
Mesembryanthemum has traditionally been used as food for the treatment of diabetes and liver 
diseases and (Bouftira, et al., 2009). It possesses biological activities, such as the anti-oxidant 
and anti-viral activity of Mesembryanthemum edule L. and Mesembryanthemum crystallinum L. 
(Bouftira, et al., 2009, Falleh, et al., 2011). Rutin, neohesperidin, hyperoside, catechin and ferulic 
acid were identified in C.edulis, and contribute to the antibacterial and antioxidant properties. It 
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also contains procyanidins and propelargonidins (Van der Watt and Pretorius, 2001; Falleh et al., 
2009). 
-Atriplex inflata Muell. 
Atriplex species have been used for their good medicinal values.  Atriplex inflata Muell extracts 
were revealed to be active against Herpes simplex viral infection (Mohammed et al., 2012).  
Many of these species has been investigated for their chemical constituents such as, terpenoids, 
flavonoids and saponins. Atriplex inflata, was reported to contain; Flavonol aglycones: 
Kaempferol, quercetin, isorhamnetin, patuletin, spinacetin and tricin, and Flavonoid sulphates 
(Mohammed et al., 2012). 
- Arthrophytum scoparium Pomel 
Arthrophytum scoparium is used in traditional medicine to treat eye disorders, and as a snuff 
powder (Boukef, 1986). A scoparium has been reported to have hepatoprotective, antioxidant, 
anticancer, antiplasmodial and larvicidal activity (Bourogaa et al., 2011; Bourogaa et al., 2013). 
Phenolic acids such as, coumaric acid, cinnamic acid, caffeoylquinic acid, were identified in A. 
scoparium as well as glycoside flavonoids such as; Isorhamnetin 3-O-β-D-xylopyranosyl 
Isorhamnetin-3-O-robinobioside and isorhamnetin-galactose-xylose (Bourogaa et al., 2011). 
- Rantherium suaveolens Desf. 
Rantherium species have been used by the local population in the production of cheese and in 
folk medicine as an antidiuretic (Hamia et al., 2013). Five kinds of ceramides was isolated from 
the aerial parts of Rantherium suaveolens and characterized by spectroscopic and chemical 
methods (Oueslati et al., 2004). Ceramides are key sphingolipid metabolites, having clinical 
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potential as therapeutics. They play the role as second messengers for different cellular processes 
mainly cell cycle arrest, differentiation, senescence, apoptosis. Moreover, it has been previously 
reported the isolation of polyacetyleneic alcohols, terpenoids, and coumarins from extracts of R. 
suaveolens (Oueslati et al., 2006). 
 
1.8. Objectives and outlines of dissertation 
Obesity is caused by the accumulation of lipid through adipogenesis in adipose tissue, and 
adipogenesis is the process by which undifferentiated precursor cells differentiate into fat storage 
cells. Excess size and number of adipocytes are known to be a hallmark of obesity; therefore, the 
inhibition of adipocyte differentiation is one of the strategies for the treatment of obesity. This 
current study attempted to investigate the beneficial effects of halophytes extracts on obesity in 
vitro using 3T3-L1 cell line model and based on the ability of these cells to differentiate from 
pre-adipocytes to mature adipocytes. Adipocyte differentiation is a multifaceted process 
involving synchronized expression of specific genes associated with each phase of adipogenesis. 
Thus, dysregulation of transcription factors (CEBP-α, PPAR-γ) and functional impairment of 
adipocyte differentiation might be appropriate targets for preventive intervention against obesity. 
Therefore, the effect of the most effective halophytes samples on this process through genes 
expression was evaluated. Maintaining high levels of PPAR-γ and CEBP-α, stimulates 
differentiation, so their regulation would be a good alternative or target for inhibition of 
differentiation. As artificial drugs fail to provide preferred effects and with side effects involved, 
the utilization of traditional and alternative medicines is fast gaining interest. Medicinal plants 
are believed to possess potential anti-obesity agents that can act through several mechanisms 
either by preventing weight gain or promoting weight loss amongst them and this may be an 
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excellent alternative strategy for developing future effective, safe anti-obesity medications or 
functional foods (Kang and Park, 2012). 
In this context our aims were: 
1- Investigation of an edible or medicinal halophyte extract (selected after screening) effect 
whether could prevent or control weight gain in C57B6J/L mice fed daily with high fat 
diet induced obesity. 
2- Test the efficiency of this extract on transgenic db/db mice in order to evaluate the 
treatment effect of obesity-related diseases such as diabetes. 
The outlines of this dissertation are summarized in the following flow chart (Fig. 1. 1.). 
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2.1. Introduction 
The uses of traditional medicine; during last decade, have expanded globally and are gaining 
popularity. The plant kingdom has become a target for the search by multinational drug 
companies and research institutes for new drugs and biologically active lead compounds (Li and 
Vederas, 2009). The world health organization (WHO) reported in 2002 that the herbal medicine 
serve the health need of about 80% of the world’s population, especially for millions of people in 
the vast rural areas of developing countries (Soltan et al., 2009). Some antioxidant compounds 
are extracted from easy sources, such as agricultural and horticultural crops, or medicinal plants. 
Among those, halophytes are naturally salt-tolerant plants that may be potentially useful for 
economical applications as new sources of natural antioxidants in dietary food (Ksouri et al., 
2009). These plants have ethno-pharmacological data indicating their utilization in folk 
medicine. Thus, the role of these medicinal species in the prevention or treatment of diseases has 
been largely attributed to their antioxidant properties associated with a wide range of bioactive 
molecules (Ivanova et al., 2005). The clinical importance of herbal drugs and polyphenols for 
treatment of diseases such as obesity and its related complications, has received considerable 
attention (Dave et al., 2012). The WHO defines obesity as an abnormal excessive fat 
accumulation detrimental to human health. Obesity has also defined as an increased adipose 
tissue mass, which is the result of an enlargement in fat cells and/or an increase in their number 
(Dave et al., 2012). These therapies have been variably efficacious on adipocyte differentiation 
and lipid accumulation in adipocytes. A number dietary inhibitors of adipose differentiation have 
been identified, including isorhamnetin (Lee et al., 2009), quercetin, resveratrol (Yang et al., 
2008), naringenin (Harmon and Patel, 2001). This family of phenolic compounds are potent 
scavengers of free radicals and potentially useful in the prevention of cancer, arteriosclerosis and 
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also have been associated with several health promoting activities such as decreasing blood sugar 
levels and reducing body weight (Ksouri et al., 2011). The main objectives of this work were (i) 
to explore the inter-specific variability of three medicinal halophytes collected in same biotope 
(salt flat) on the basis of their phenolic contents and antioxidant activities, (ii) to screen other 
halophytes samples collected in different biotopes (coastal regions, salt flats, south regions) on 
the basis of their phenolic contents and antioxidant activities, (iii) to select the most promising 
species based on obtained results as well as on scientific reports, in order to test their efficiency 
on inhibiting pre-adipocyte differentiation and lipid accumulation in 3T3-L1 cells as a model in 
obesity research.  The final goal was to focus on the ability of some selected medicinal and 
edible halophytes to reduce or alleviate obesity and related-complications in vitro or in vivo 
models. 
2.2. Materials and Methods 
2.2.1. Plant sampling of three halophytes collected in same biotope  
Three halophytic species (Limonium densiflorum, Plantago crassifolia and Suaeda maritima) 
were screened in this study. Shoots were collected in August 2009 from “Sidi El Hani” a salt flat 
located at 30 kilometers southwest of Sousse and 20 kilometers east of Kairouan in Tunisia, 
African continent. This locality is characterized by a semi-arid climate with less rainfall < 200 
mm/year and higher salinity mean (20 g/L). The collected samples were rinsed with distilled 
water, kept in laboratory temperature; oven dried at 60° C and then ground finely using a ball 
mill type “Dangoumeau”. The plant powder obtained was stored under refrigeration at 4° C for 
different analysis. 
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2.2.2. Preparation of plant extracts 
Extracts were obtained by magnetic stirring of 3 g dry powder in 80% aqueous methanol (v/v) 
for 30 min. Then were kept for 24 h at 4°C, filtered through a Whatman No. 4, filter paper, and 
evaporated under vacuum. Then, they were stored at 4°C until analysis. 
2.2.3. Plant sampling of halophytes from different locations 
Arial parts of halophyte samples were collected during August 2010 from different type of 
biotopes. Nitraria retusa, Tamarix gallica and Atriplex inflata, were collected from a salt flat 
called “Sabkha El kelbia” (Kairouan, Tunisia) with a semi-arid climate. Mesembryanthemum 
edule sample was collected from the coastal region “Soliman” (Nabeul, Tunisia) with sub-humid 
climate. Rantherium suaveolens and Arthrophytum scoparium samples were collected from the 
south region of Tunisia (Gabes) with a Saharan climate. The collected samples were rinsed with 
distilled water, kept in laboratory temperature; oven dried at 60°C and then ground finely using a 
ball mill type “Dangoumeau”. The plant powder obtained was stored at room temperature for 
further experiments. 
2.2.4 Extraction methods 
Seventy percent ethanol extraction of halophytes samples was conducted with 10% (w/v). The 
ethanol extracts were kept in the dark at room temperature for 2 weeks, with shaking at least 
once a day. The liquid fraction was then collected, filtered through 0.22 μm filter (MILLIPORE, 
U.S.A.), and concentrated using SpeedVac (SCRUM Inc., Japan). The dried residue was re-
dissolved in seventy percent ethanol or milliQ by vortexing and stored at -80°C for further 
experiments. 
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2.2.5. Colorimetric quantification of phenolics 
2.2.5.1 Determination of total polyphenol content 
Colorimetric quantification of total polyphenols was determined, as described by Dewanto et al. 
(2002). An aliquot of 125 µL of diluted extract were added to 500 µL of distilled water and 125 
µL of the Folin-Ciocalteu reagent. The mixture was shaken, before adding 1250 µL Na2CO3 
(7%), adjusting with distilled water to a final volume of 3 mL, and mixed thoroughly. After 
incubation for 90 min at 23 °C in the dark, the absorbance versus prepared blank was read at 760 
nm. A standard curve of gallic acid was used. Total phenolic content of organs was expressed as 
mg gallic acid equivalents per gram of dry weight (mg GAE/g DW) through the calibration curve 
with gallic acid, ranging from 0 to 400 µg/mL. All samples were analyzed in triplicate. 
2.2.5.2 Estimation of total flavonoid content 
Total flavonoid content was measured by a colorimetric assay developed by Dewanto et al. 
(2002). An aliquot of suitable diluted samples of standard solution of (+)-catechin was added to 
NaNO2 and mixed for 6 min, before adding 0.15 mL of a freshly prepared AlCl3 (10 g/100 mL). 
After 5 min, 0.5 mL of 1 mol/ L NaOH solution was added. The final volume was adjusted to 2.5 
mL with distilled water and thoroughly mixed. Absorbance was measured at 510 nm. Total 
flavonoid content was expressed as mg catechin per gram of DW (mg CE/g DW), through the 
calibration curve of (+)-catechin, ranging from 0 to 400 µg/mL. All samples were analyzed in 
triplicate. 
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2.2.5.3. Determination of condensed tannin content  
The analysis of condensed tannins was carried out to the method of Sun et al. (1998). To 50 µL 
of appropriately diluted sample, 3 mL of 4% methanol vanillin solution and 1.5 mL of 
concentrated hydrochloric acid were added. The mixture was allowed to stand for 15 min, and 
the absorption was measured at 500 nm. Total condensed tannins amount was expressed as mg 
(+)-Catechin g 
-1
 DW. The calibration curve range of catechin was established between 0 and 
400 µg/mL. All samples were analyzed in triplicate. 
2.2.6. Assessment of antioxidant activities  
2.2.6.1. Evaluation of total antioxidant capacity 
The assay is based on the reduction of Mo (VI) to Mo (V) by the extract and subsequent 
formation of a green phosphate/Mo (V) complex at acid pH (Prieto et al., 1999). An aliquot (0.1 
mL) of plant extract was combined to 1 mL of reagent solution (0.6 M sulfuric acid, 28 mM 
sodium phosphate and 4 mM ammonium molybdate). The tubes were incubated in a thermal 
block at 95°C for 90 min. After, the mixture cooled to room temperature. The absorbance of each 
sample was measured at 695 nm against a blank. The total antioxidant activity was expressed as 
mg gallic acid equivalent per gram dry weight (mg GAE/g DW). The calibration curve range was 
0–500 µg/mL. All samples were analyzed in triplicate.  
2.2.6.2. Scavenging ability on DPPH radical 
Scavenging ability of organ extracts was measured according to Hanato et al. (1988). One 
milliliter of the extract at known concentrations was added to 0.25 mL of a DPPH
.
 methanolic 
solution. The mixture was shaken vigorously and left standing at room temperature for 30 min in 
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the dark. The absorbance of the resulting solution was then measured at 517 nm and 
corresponded to the ability of extracts to reduce the stable radical DPPH to the yellow-colored 
diphenylpicrylhydrazine. The antiradical activity was expressed as IC50 (µg/mL), the extract dose 
required to cause a 50% inhibition. A lower IC50 value corresponds to a higher antioxidant 
activity of plant extract. The ability to scavenge the DPPH radical was calculated using the 
following equation (1): 
DPPH
. 
scavenging effect (%) = [(A0-A1)/A0]*100    (1) 
Where, A0 and A1 are the absorbance values of the control and of the sample at 30 min, 
respectively. All samples were analyzed in triplicate. 
2.2.6.3. Iron reducing power 
The capacity of plant extracts to reduce Fe
3+
 was assessed by the method of Oyaizu (1986). 
Methanol extract (1 mL) was mixed with 2.5 mL of sodium phosphate buffer (0.2 M, pH 6.6) 
and 2.5 mL of 1% potassium ferricyanide, and the mixture was incubated at 50 °C for 20 min. 
After that, 2.5 mL of 10% trichloroacetic acid were added, and the mixture was centrifuged at 
650×g for 10 min. The upper layer fraction (2.5 mL) was mixed with 2.5 mL of deionized water 
and 0.5 mL of ferric chloride and thoroughly mixed. The absorbance was measured at 700 nm 
and ascorbic acid was used as a positive control. A higher absorbance indicates a higher reducing 
power. EC50 value (mg/mL) is the effective concentration giving an absorbance of 0.5 for 
reducing power and was obtained from linear regression analysis. 
2.2.7. Cell culture 
Murine 3T3-L1 preadipocytes (Riken Tsukuba japan) were maintained in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin 
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(5000 μg/mL)-streptomycin (5000 IU/mL) in 75-cm2 tissue culture flasks. Medium was changed 
every 3 days and cell passage was carried out at 80% confluence at one on two ratio using 0.25% 
trypsin (1 mM EDTA). 3T3-L1 cells were cultured in a humidified incubator at 37° C and 5% 
CO2. 
2.2.8. Treatment of halophyte extracts on 3T3-L1 cells, pre-adipocytes differentiation and 
oil-Red-O staining procedures 
3T3-L1 pre-adipocytes were seeded into 96-well plates at 1.0 x 10
4
 cells/well, and cultured for 
additional two days until full confluence. Two days later (Day 0), cells were incubated with a 
differentiation cocktail (MDI) containing 1/10 insulin solution, 1/10 dexamethasone solution and 
1/10 3-isobutyl-1-methylxanthine solution in standard culture medium for 3 days followed by 
additional 48 h with standard culture medium containing insulin alone, which will be changed 
every 2 days until full differentiation of pre-adipocytes into adipocytes. To investigate the effect 
of halophyte extracts; Nitraria retusa (NR), Tamarix gallica (TG), Atriplex inflata (AI), 
Mesembryanthemum edule (ME), Arthrophytum scoparium (AS) and Rantherium sueavelons 
(RS); on adipogenesis in 3T3-L1; 25, 50, 100, 200 and 400 μg/mL doses of each extract were 
added to the differentiation-induction and differentiation-maintenance media. The staining 
procedure was conducted according to the adipogensis assay kit (Cayman chemical company). 
The absorbance was read at 490 nm with a 96-well plate reader. The lipid droplet content was 
reported as percentage of control cells, and isorhamnetin-treated cells were used as positive 
control. 
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2.2.9. Cell proliferation assay (MTT assay) 
Cell proliferation was investigated by MTT (3-(4-5-Dimethylthiazol-2-yl)-2-5-
diphenyltetrazolium bromide) assay. 3T3-L1 cells were seeded in 96-well plates at 1 × 10
5
 
cells/mL. After incubation for 24 h, 48 h and 72 h (Pre-adipocytes) and 7 days (adipocytes) 
halophytes samples, (NR, TG, AI, ME, AS and RS), diluted in medium was added at final 
concentrations of 25, 50, 100, 200, 400  μg/mL. MTT was added after treatment for 24, 48, 72 h 
and 7 days, and the resulting formazan was completely dissolved by 100 μL of 10% sodium 
dodecyl sulfate (SDS) for 24 h. The absorbance was determined at 570 nm in a multi-detection 
microplate reader (Power-scan HT, Dainippon Pharmaceutical, NJ, USA). Absorbance caused by 
the ability of the sample to reduce MTT or by its color, was corrected using plates as blanks, 
prepared in the same conditions in the absence of cells.   
2.2.10. RNA isolation from 3T3-L1 adipocytes and real-time-PCR analysis 
Liver samples were prepared (50 mg) and homogenized with a Polytron homogenizer. Then total 
RNA was purified using the ISOGEN kit (Nippon GeneCo. Ltd., Japan) following the 
manufacturer’s instructions. Total RNA was quantified using Thermo Scientific Nanodrop 2000 
(USA), and the reverse transcription reactions were performed using the Superscript III reverse 
transcriptase kit (Invitrogen, Carlsbad/CA, USA) using 1 µg of total RNA. Briefly, RNA was 
denatured by incubation at 65°C for 5 min, with 1 µL oligo (dT) primers, and chilled at 4°C. 
Then SuperScript III reverse transcriptase was added and the reaction mix was then incubated at 
42°C for 60 min, then 10 min at 70°C (Han and Isoda, 2009). The expression of Peroxisome 
proliferator-activated receptor gamma (PPAR-γ1), CCAT/enhancer binding protein alpha (CEBP-
α), Lipoprotein lipase (LPL), Fatty acid synthase (FAS); were determined by real-time PCR using 
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Beta –actin as housekeeping gene. Primers and TaqMan probes used for these experiments were 
purchased from Applied Bio-systems. Primers were inventoried gene expression assays. TaqMan 
real-time PCR amplification reactions were performed in a 20 µL reaction mixtures containing: 
10 µL of TaqMan Universal PCR Master Mix UNG (2X), 9 µL of template c-DNA (100 ng µL
-1
) 
and 1 µL of the corresponding primer/probe mix, using an AB 7500 fast real-time system 
(Applied Bio-systems). For the amplification, the following cycling conditions were applied: 2 
min at 50°C, 10 min at 95°C, and 40 cycles of 15 s at 95 °C / 1 min at 60°C. 
2.2.11. Statistical analysis 
All experiments were repeated at least three times. Data were expressed as the mean ± SD. 
Differences between control and treatments were assessed by Student’s unpaired t-test. P values 
below 0.05, 0.01, and 0.001 were considered significant. 
2.3. Results 
2.3.1. Inter-specific variability of three medicinal halophytes collected in same biotope (Salt 
flat) on the basis of their phenolic contents and antioxidant activities. 
Based on the absorbance values after reaction with Folin–Ciocalteu reagent, results of the 
colorimetric analysis are given in Table 2. 1. The amount of total polyphenol was species-
dependent. Limonium densiflorum displayed the highest polyphenol content, flavonoids content 
as well as the condensed tannin content; 66.80± 1.83, 18.74± 0.64 and 42.43± 1.52, respectively. 
These results reveal the richness of L. densiflorum in phenolics compared to the other 2 species, 
despite their presence in the same biotope and undergo almost the same environmental 
conditions (semi-arid climate).Concerning the antioxidant capacity evaluated by 3 
complementary tests (TAA, DPPH, Fe reducing power), L. densiflorum was also the most 
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efficient species as compared to the 2 other halophytes (Table 2. 2.). The superiority of L. 
densiflorum may be related to the higher phenolic content and quality of this species. 
 
2.3.2. Inter-specific variability of six halophytes collected in different biotopes (coastal 
region, salt flats and south regions on the basis of their phenolic contents and antioxidant 
activities. 
Results of phenolic contents and antioxidant activities of six halophytes collected in different 
biotopes are summarized in Table 2. 3. and Table 2. 4. It was clearly demonstrated that the 
environmental factors and climate changes affected the variability of halophytes on the basis of 
their phenolic contents and antioxidant activities. These results revealed also a positive 
correlation between the polyphenols amounts and the antioxidant activities. However it was also 
reported in many studies that the biological activities depend not only on the quantity of 
bioactive components but also in many cases depend on the quality or the chemical structure of 
these metabolites. 
2.3.3. Effect of halophyte samples on cell differentiation and lipid droplet formation in 3T3-
L1 cells 
Adipogenesis assay was performed to investigate the effect of halophyte samples on the 
adipocyte differentiation and on the lipid droplets accumulation in 3T3-L1 cells using Oil red O 
staining. Differentiated 3T3-L1 cells were treated every two days with different halophyte 
extracts at various concentration and with 25 μM isorhamnetin (as a positive control), for 7 days. 
Based on Oil-red-O content quantification, results showed that Nitraria retusa sample (NR) 
treatments at 25, 50, 100, 200 and 400 μg/mL, in 3T3-L1 cells could inhibit the lipid droplet 
accumulation compared to untreated cells, in dose dependent manner (Fig. 2. 1. A.). The 
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triglyceride accumulation significantly decreased to 76.60 ± 7.30 %, 69.08 ± 8.08 %, 62.90 ± 
4.80 %, 46.80 ± 7.50 %, and 42.70 ± 2.10% respectively (Fig. 2. 1. A.). NRE treatments at doses 
of 200 and 400 μg/mL, showed a similar strong effect as isorhamnetin (25 µM). Moreover, we 
noticed that NRE treatment in 3T3-L1 was accompanied by modulation of cell hypertrophy 
rather than cell hyperplasia as indicated in microscopic observation. Thus NRE treatment might 
induce the cell differentiation into smaller adipocytes compared to untreated cells. Another 
sample showed a very interesting data in increasing the lipid accumulation in dose dependent 
manner, is Tamarix gallica. Its ethanolic extract (TG) exhibit a strong anti-adipogenic activity 
leading to highly significant reduction in lipid accumulation within cells expressed by a low Oil-
Red content as shown in Fig. 2. 1. B.. Regarding the rest of samples, results showed that not all 
these samples are effective in reducing the lipid content within cells. Only some determined high 
concentrations of certain samples were shown to inhibit lipid droplets accumulation within 3T3-
L1 cells. In addition, results of Arthrophytum scoparium (AS), Rantherium suavealens (RS), 
Mesembryanthemum edule (ME) and Atriple inflata (AI) halophytes samples did not show dose-
dependent effect (Fig. 2. 2.). Therefore, it is necessary to correlate the obtained results with the 
MTT assay results in next section. 
2.3.4. Effect of halophyte samples on cell proliferation and viability 
Observation of the cell morphological changes of 3T3-L1 adipocytes after treatment with 
different doses of Nitraria retusa extract (NR), revealed a decrease in cell size especially in cells 
treated with high concentrations without affecting cell viability of differentiated 3T3-L1 
adipocytes after 7 days (Fig. 2. 3. A.).  The higher doses of NR (100, 200 and 400 μg/mL), 
slightly decrease cell viability of pre-adipocytes after 48 h of treatments (Fig. 2. 5. A.) .However, 
Tamarix gallica extract (TG) treatment was shown to inhibit cell proliferation in dose dependent 
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manner in both differentiated adipocytes (Fig. 2. 3. B.) and pre-adipocytes (Fig. 2. 5. B.). Thus, 
NR and TG extracts act, finally, with different ways but have a similar effect; which is the 
reduction of lipid accumulation within cells. Concenring other samples of halophytes; AS, RS, 
ME and AI, their ethanolic extracts did not significantly affect the cell viability and cell 
proliferation of 3T3-L1 cells as shown in Fig. 2. 6. and Fig. 2. 7., respectively. 
2.3.5. Cell viability and cell number by Flow cytometry (Via-Count) 
To understand whether the proliferation inhibition effect was due to cell death or growth 
inhibition, we determined the cell number and cell viability after treatment with either Nitraria 
retusa extract or Tamarix gallica extract. Results showed that both extracts treatments didn’t 
affect the cell viability compared to the control (Fig. 2. 9. B. and C.). However the cell number 
was decreased by around 20% after Tamarix gallica extract treatments (50 µg/mL and 100 
µg/mL), and was increased by around 50% and 100% respectively for 200 µg/mL and 400 
µg/mL of Nitraria retusa extract (Fig. 2. 9. E. and F.). The positive control used for this study 
(Isorhamnetin at 25 μM) increase little cell viability (Fig. 2. 9. A.) and cell number (Fig. 2. 9. 
D.). 
2.3.6. Effect of NR and TG treatments on the expressions of genes related to 3T3-L1 
differentiation and lipid accumulation 
Gene expressions showing the effect of Nitraria retusa extract (NR) and Tamarix gallica extract 
(TG) on the genes associated with fat differentiation and lipogenesis were analyzed by real-Time 
PCR. The PPAR-γ mRNA expression and CEBP-α mRNA expression were significantly induced 
by NR treatments (200, 400 μg/mL). Their target genes FAS, LPL and SREBP-1c were also up-
regulated for both concentrations (200 and 400 μg/mL) (Fig. 2. 10. and Fig. 2. 11.). These data 
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could be related to the increasing of cell number caused by these two doses of NRE which lead 
to the induction of differentiation into smaller adipocytes. However, TGE treatments showed 
different effects especially for PPAR-γ which was down-regulated by the high dose (100μg/mL) 
causing the down-regulation of their target genes FAS and LPL (Fig. 2. 10. and Fig. 2. 11.). 
CEBP-α, a gene with anti-mitotic and anti-proliferative effect, its mRNA expression was highly 
overexpressed by TG treatment which could explain or reflect the growth inhibition of 3T3-L1 
cells leading to the inhibition of cell differentiation and lipid accumulation. 
2.4. Discussion 
The inter-specific variability illustrated by phenolic amount showed the importance of 
endogenous factors on the distribution of phenolics. Indeed, the work of Ksouri et al., (2008), on 
some halophytic species, has shown the involvement of intrinsic factors on the biosynthesis of 
these molecules. In addition, Djeridane et al., (2006) indicate that the secondary metabolites are 
more variable in plants of different species (inter-specific variability) than in plants of the same 
species (intra-specific variability). The superiority of L. densiflorum on antioxidant activities 
may be related to the higher phenolic content and quality of this species. In fact, Ozgen et al., 
(2008) displayed a considerable variation in phenolics correlated to antioxidant properties of 
pomegranate cultivars from Turkey, with significant positive correlations (ranged from 0.82 to 
0.96) between antioxidant capacity (FRAP and TEAC), total phenolic (TP) and total anthocyanin 
(TMA). Our data demonstrated a great inter-specific variability on antioxidant capacities which 
was most probably, determined by genetic factors as proposed by others studies (Reynertson et 
al, 2008; Sousa et al., 2006). Evaluation of phenolic contents and antioxidant activities of 
different halophytes species collected from different locations with different environmental and 
climatic factors, showed a very big variability dependent on the species and probably their 
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mechanisms of salt or drought tolerance. These results revealed also a positive correlation 
between the polyphenols amounts and the antioxidant activities. However it was also reported in 
many studies that the biological activities depending not only on the quantity of bioactive 
components but also in many cases depend on the quality or the chemical structure of these 
metabolites (Balasundram et al., 2006). In other hand, the anti-adipogenic activity was variable 
and dependent on species and probably correlated with their richness on polyphenols either on 
the quantity or on the quality. Two different species (NR and TG) showed a strong activity on 
inhibiting the 3T3-L1 cell differentiation and lipid accumulation by regulating either size or 
number of cells. Excess size and number of adipocytes are known to be a hallmark of obesity; 
therefore regulation of the malfunction of the cellular metabolism, and the impairment of 
adipocyte differentiation might be appropriate targets for preventive interventions against 
obesity. In our study, Nitraria retusa extract could reduce the lipid accumulation in dose 
dependent manner by modulation of cell size or hypertrophy of adipocytes as well as cell number 
or hyperplasia; consequently it induced the differentiation with smaller lipid droplets compared 
to the control. In same regard, it has been reported that the increased number of small adipocytes 
and the decreased number of large adipocytes in white adipose tissues of troglitazone-treated 
obese rats appear to be an important mechanism by which increased expression levels of tumor-
necrosis-factor-α (TNF-α) and higher levels of plasma lipids are normalized, leading to 
alleviation of insulin resistance (Okuno et al., 1998). In the other side, Tamarix gallica extract 
was demonstrated that could inhibit lipid formation through the inhibition of cell proliferation 
and cell growth by decreasing the cell number without affecting the cell viability. The 
differentiation of 3T3-L1 pre-adipocytes is regulated particularly by the action of PPAR and 
CEBP families. It was reported that their under-expression reduce the maturation of 3T3-L1 
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adipocytes (Rosen et al., 2002). PPAR- γ and CEBP- α are known to play a synergistic role in fat 
cell function and adipocyte differentiation of pre-adipocytes. Their cooperative functions lead to 
maintain high levels of PPAR-γ and CEBP-α expressions which stimulate consequently 3T3-L1 
differentiation (Cristancho et al., 2011), so their down-regulation would be a good alternative or 
target for inhibition of differentiation. However, high gene expression level of PPAR-γ has been 
reported to be related to the induction of 3T3-L1 differentiation in small adipocytes by increasing 
their number via troglitazone action which in turn alleviates the insulin resistance in obese 
zucker rats (Okuno et al., 1998). This reported study is concordant with our findings concerning 
Nitraria retusa extract. In the other hand, Tamarix gallica extract was shown to inhibit cell 
differentiation due to the under-expression of adipocyte differentiation-related genes (Fig. 2. 10. 
and Fig. 2. 11.). It was shown that many natural products beneficially affect adipocytes during 
specific stages of development (Fukumitsu et al., 2008; Rayalam et al., 2008; Chen et al., 2009). 
Treatment with berberine elevated expression levels of the DNA binding proteins interacting 
with CEBP-α and inhibitded adipocyte differentiation (Hu et al., 2009). In 3T3-L1 cells, luteolin 
exhibited anti-adipogenic effects by inhibiting the transactivation of PPAR-γ (Park et al., 2009). 
In other animal studies, green tea seed oil used as supplement, suppressed expression of 3T3-L1 
differentiation-related PPAR-γ and CEBP-α in adipose tissue (Kim et al., 2008). SREBP-1c, a 
transcription factor that controls fatty acid synthase, is additional regulator of adipogenesis in 
parallel with PPAR-γ and CEBP-α (Drira et al., 2011). In this regard, and, in many studies many 
compounds have been described as inhibiting adipocyte differentiation via SREBP-1c regulation 
(Kim et al., 2010). In current study , Tamarix gallica extract inhibit probably the growth of 3T3-
L1 cells from the first two days after differentiation induction, leading to an inhibition in cell 
proliferation and later differentiation thus a strong reduction in lipid accumulation within cells 
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which was very clear in final day of full differentiation and conformed by cell number and cell 
viability assays. In same context, it was reported that oleuropein could inhibit differentiation 
during early stages, which runs parallel to clonal expansion; it inhibited DMI induced clonal 
expansion and delayed the cell cycle progression (Drira et al., 2011). Several studies revealed 
that arresting or delaying the cell cycle of 3T3-L1 cells during the first two days of 
differentiation decreased cell number and inhibited the differentiation rate to adipocytes (Lee et 
al., 2009). 
2.5. Conclusion 
Taken together all results, we concluded that Tamarix gallica extract mixture played a role in 
decreased pre-adipocytes proliferation for the possible anti-obesity via growth inhibition of pre-
adipocytes in early stages of differentiation. In addition, this current study showed that Nitraria 
retusa extract mixture could be a potent anti-obesity agent via alleviation of lipid accumulation 
by increasing the number of small adipocytes leading probably to an alleviation of insulin 
resisitance within adipose tissue. 
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Table 2. 1. Variability of total polyphenol, flavonoid, and condensed tannin contents of three 
halophytes collected in same biotope. 
Shoot sample Total polyphenol 
content  
(mgGAE.g
-1
DW) 
Total Flavonoid 
content  
(mgCE.g
-1
DW) 
Condensed tannin content 
(mgCE.g
-1
DW) 
Limonium densiflorum            66.80± 1.83 18.74± 0.64          42.43± 1.52 
Plantago crassiflolia             9.70± 0.29 6.42± 0.04           0.30± 0.05 
Sueada maritima            5.93± 0.15 5.25± 0.15           0.27± 0.05 
 
 
 
 
Table 2. 2. Evaluation of Antioxidant activities of three halophytes collected in same biotope. 
 
Shoot sample 
Total antioxidant activity 
(mgGAE.g
-1
DW) 
DPPH test 
(IC50 µg.mL
-1
) 
Fe-reducing power 
(EC50 µg.mL
-1
) 
Limonium densiflorum           98.30± 4.18  5.97± 0.64        90.00± 0.57 
Plantago crassiflolia          13.50± 0.17          57.67± 2.51       1700.00± 26.45 
Sueada maritima          14.31± 0.10 121.00± 6.55       3050.00± 36.05 
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Table 2. 3. Variability of total polyphenol, flavonoid, and condensed tannin contents of six 
halophytes collected from different biotopes. 
 
 
 Plant species 
Total polyphenol 
content 
(mgGAE.g
-1
DW) 
Total Flavonoid 
content  
(mgCE.g
-1
DW) 
Condensed tannin 
content 
(mgCE.g
-1
DW) 
Tamarix gallica  152.80±  3.21        43.40± 1.21        123.44  ± 2.61 
Nitraria retusa   42.70±  1.12      22.60± 0.91          21.87± 1.21 
Mesembryanthemum edule   73.10± 0.72       45.00± 0.82           7.50± 0.07 
Atriplex  inflata    5.32± 0.07       2.90± 0.03           3.50± 0.02 
Arthrophytum scoparium    6.80± 0.09       2.62± 0.02           3.23± 0.01 
Rantherium suaveolens    58.92± 1.32        21.75± 1.11         38.82± 2.13 
 
 
 
Table 2. 4. Evaluation of Antioxidant activities of six halophytes collected from different 
biotopes. 
 
 
 Plant species 
 
Total antioxidant 
activity (mgGAE.g
-1
DW) 
 
DPPH test 
(IC50 µg.mL
-1
) 
 
Fe-reducing power 
(EC50 µg.mL
-1
) 
Tamarix gallica 123.70±  2.52        2.50± 0.05       82.00  ± 2.61 
Nitraria retusa          45.82±  1.71        22.50± 0.02      160.00± 5.20 
Mesembryanthemum edule          82.15±  2.21       21.36±  2.00       110.00± 4.31 
Atriplex  inflata         10.28±  0.50       97.23± 3.21      2150.00± 17.21 
Arthrophytum scoparium         17.22± 0.72      109.15±  4.10      1020.00± 15.10 
Rantherium suaveolens         32.19± 1.23        8.52± 0.56        180.00± 5.10 
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Fig. 2. 1. Effects of halophytes extracts: NR (A) and TG (B), using different concentrations (25, 
50, 100, 200 and 400 μg/mL), on lipid droplet content in 3T3-L1 cells.  
Fat droplets in adipocytes differentiated for 7 days with or without sample extracts and 
isorhamnetin at 25 μM dose (the positive control) treatments were stained with oil Red-O dye 
and examined used a light microscope. Relative Oil-Red-O absorbance was measured at 490 nm. 
Lipid droplet accumulation in treated cells was expressed as a percentage of control (untreated 
cells). Bars represent mean ± SD, n=3, * p<0.05, ** p<0.01, *** p<0.001 vs. control. 
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Fig. 2. 2. Effects of halophytes extracts: AS (A), RS (B), ME(C) and AI (D) using different 
concentrations (25, 50, 100, 200 and 400 μg/mL), on lipid droplet content in 3T3-L1 cells.  
Fat droplets in adipocytes differentiated for 7days with or without sample extracts and 
isorhamnetin at 25 μM dose (the positive control) treatments were stained with oil Red-O dye 
and examined used a light microscope. Relative Oil-Red-O absorbance was measured at 490 nm. 
Lipid droplet accumulation in treated cells was expressed as a percentage of control (untreated 
cells). Bars represent mean ± SD, n=3, * p<0.05, ** p<0.01, *** p<0.001 vs. control. 
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Fig. 2. 3. Effects of halophytes extracts: NR (A) and TG (B) using different concentrations (25, 
50, 100, 200 and 400 μg/mL) and isorhamnetin at 25 μM dose (the positive control), on 3T3-L1 
pre-adipocytes viability after cell differentiation (7 days treatment). Bars represent mean ± SD, 
n=3, ** p<0.01, *** p< 0.001 vs. control. 
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Fig. 2. 4. Effects of halophytes extracts: NR (A) and TG (B) using different concentrations (25, 
50, 100, 200 and 400 μg/mL), on 3T3-L1pre-adipocytes proliferation (24 hours treatment). Bars 
represent mean ± SD, n=3, ** p<0.01, *** p<0.001 vs. control. 
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Fig. 2. 5. Effects of halophytes extracts: NR (A) and TG (B) using different concentrations (25, 
50, 100, 200 and 400 μg/mL), on 3T3-L1 pre-adipocytes proliferation (48 hours treatment). Bars 
represent mean ± SD, n=3, * p<0.05, ** p<0.01 vs. control. 
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Fig. 2. 6. Effects of halophytes extracts: AS (A), RS (B), ME(C) and AI (D) using different 
concentrations (25, 50, 100, 200 and 400 μg/mL) isorhamnetin at 25 μM dose (the positive 
control), on 3T3-L1 pre-adipocytes viability after cell differentiation (7 days treatment). Bars 
represent mean ± SD, n=3, * p<0.05, ** p<0.01 vs. control. 
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Fig. 2. 7. Effects of halophytes extracts: AS (A), RS (B), ME(C) and AI (D) using different 
concentrations (25, 50, 100, 200 and 400 μg/mL), on 3T3-L1 pre-adipocytes proliferation (24 
hours treatment). Bars represent mean ± SD, n=3, * p<0.05, *** p<0.001 vs. control. 
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Fig. 2. 8. Effects of halophytes extracts: AS (A), RS (B), ME(C) and AI (D) using different 
concentrations (25, 50, 100, 200 and 400 μg/mL), on 3T3-L1pre-adipocytes proliferation (48 
hours treatment). Bars represent mean ± SD, n=3, * p<0.05, ** p<0.01 vs. control. 
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Fig. 2. 9. Effect of Isorhamnetin (Iso), Nitraria retusa extract (NR) and Tamarix gallica extract 
(TG) on the cell number and viability of 3T3-L1 cells. (A), (B), (C): Percentage of viability in 
3T3-L1 cells treated with Iso, NR and TG, repectively, to 7 days. (D), (E), (F): Relative number 
of viable cells after treatment with Iso, NR and TG, repectively, after cell differentiation up to 7 
days 3T3-L1 cells were treated at a final concentration of 25 μM of isorhamnetin; 50, 100 μg/mL 
of TG  and 200, 400 μg/mL of NR . Cell number and cell viability were measured by flow 
cytometry (Guava ViaCount). Bars represent mean ± SD, n=3, * p<0.05 vs. control. 
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Fig. 2. 9. Effect of Isorhamnetin (Iso), Nitraria retusa extract (NR) and Tamarix gallica extract 
(TG) on the cell number and viability of 3T3-L1 cells. (A), (B), (C): Percentage of viability in 
3T3-L1 cells treated with Iso, NR and TG, repectively, to 7 days. (D), (E), (F): Relative number 
of viable cells after treatment with Iso, NR and TG, repectively, after cell differentiation up to 7 
days 3T3-L1 cells were treated at a final concentration of 25 μM of isorhamnetin; 50, 100 μg/mL 
of TG  and 200, 400 μg/mL of NR . Cell number and cell viability were measured by flow 
cytometry (Guava ViaCount). Bars represent mean ± SD, n=3, ** p<0.01 vs. control. 
 
 
 
 
D 
 
 
 
 
 
 
 
 
 
 
 
 E F 
 
 
 
 
 
 
 
 
 
 
49 
 
 
 
Fig. 2. 10. Effect of Nitraria retusa extract (NR) and Tamarix gallica (TG) treatments on the 
expressions of genes related to 3T3-L1 differentiation and lipid accumulation after 7 days of 
incubation. (A) Effect of NR (200, 400 μg/mL) on mRNA of PPARγ expression in 3T3-L1 
adipocytes. (B) Effect of TG (50, 100 μg/mL) on mRNA of PPARγ expression in 3T3-L1 
adipocytes. (C) Effect of NR (200, 400 μg/mL) on mRNA of CEBP-α expression in 3T3-L1 
adipocytes. (D) Effect of TG (50, 100 μg/mL) on mRNA of CEBP-α expression in 3T3-L1 
adipocytes. Bars represent mean ± SD, n=3, * p<0.05, ** p<0.01, *** p<0.001 vs. control. 
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Fig. 2. 11. Effect of Nitraria retusa extract (NR) and Tamarix gallica (TG) treatments on the 
expressions of genes related to 3T3-L1 differentiation and lipid accumulation after 7 days of 
incubation. (A) Effect of NR (200, 400 μg/mL) on mRNA of FAS expression in 3T3-L1 
adipocytes. (B) Effect of TG (50, 100 μg/mL) on mRNA of FAS expression in 3T3-L1 
adipocytes. (C) Effect of NR (200, 400 μg/mL) on mRNA of LPL expression in 3T3-L1 
adipocytes. (D) Effect of TG (50, 100 μg/mL) on mRNA of LPL expression in 3T3-L1 
adipocytes. (E)  Effect of NR (200, 400 μg/mL) on mRNA of SREBP-1c expression in 3T3-L1 
adipocytes. (F)  Effect of TG (50, 100 μg/mL) on mRNA of SREBP-1c expression in 3T3-L1 
adipocytes.Bars represent mean ± SD, n=3, ** p<0.01, *** p<0.001 vs. control. 
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CHAPTER 3 
 
 
 
Anti-obesity effects of an edible halophyte Nitraria retusa (Forsk.) in 
C57B6J/L mice fed a high fat diet-induced obesity 
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3.1. Introduction 
Obesity is rapidly growing epidemic worldwide, presenting an increase in the risk of morbidity 
and mortality in many countries across the world (WHO, 2012). It has become an increasingly 
prevalent public health problem and represents the complex interaction of genetic, 
developmental, behavioral, and environmental influences (Goran, 2000). Moreover, obesity is 
fundamentally a problem of energy balance in that self-evidently it can develop when energy 
intake exceeds energy expenditure, resulting in fat accumulation and excessive adipose tissue 
mass. Adipose tissue, in addition to its function as the major storage depot for triglycerides, is an 
active endocrine tissue sensing metabolic signals and secreting hormones called adipocytokines 
that affect whole-body energy homeostasis (Dridi et al., 2009). Since it is an endocrine organ, it 
has a fundamental role in metabolism and homeostasis regulation and where numerous chemical 
messengers called adipokines are released for better communication. The production and 
secretion of an excess or insufficient amount of adipokines may provide a molecular link 
between increased adiposity and the development of diabetes mellitus, metabolic syndrome and 
cardiovascular diseases (Hidekuni et al., 2008). The main metabolic fuels of the body are 
glucose, fatty acids and ketone bodies. In the metabolic homeostasis of the body as a whole, the 
liver occupies a central position. Indeed, besides building up glycogen in its own cells, the liver 
plays an essential role in the synthesis of adipose tissue triglycerides, by producing very- low –
density lipoproteins. Furthermore, the liver furnishes oxidizable substrates, not only to meet its 
own needs, but also to cover those of other tissues (Van Den Berghe, 1991). Besides, it has been 
reported that the liver plays an important role in modulating western diet-associated metabolic 
disorders. High-fat diets significantly alter the expression of many genes related to lipid, 
cholesterol and oxido-reductive metabolism (Radonjic et al., 2009). Nowadays, diets high in fats 
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tend to promote obesity; hence inhibition of digestion and absorption of dietary fats is a 
biological remedy in treating obesity (Gooda et al., 2012). As synthetic drugs fail to give desired 
effects and with side effects involved, the utilization of traditional and alternative medicines is 
fast gaining acceptance. Medicinal plants are believed to harbor potential anti-obesity agents that 
can act through various mechanisms either by preventing weight gain or promoting weight loss 
amongst them and this may be on excellent alternative strategy for developing future effective, 
safe anti-obesity drugs (Kamiya et al., 2012). Halophytes are a salt-tolerant species from salt and 
arid regions and desert that can tolerate a wide range of environmental conditions and resist to 
abiotic stresses such as salt, high temperature and luminosity, and drought stresses (Ksouri et al., 
2009). In fact, able to withstand and quench these severe environmental stresses, halophytes are 
equipped with powerful antioxidant systems constitute mainly on phenolic compounds so called 
“stress metabolites”. These plants have ethno-pharmacological data indicating their utilization in 
folk medicine. Thus, the role of these medicinal species in the prevention or treatment of 
diseases has been largely attributed to their antioxidant properties associated with a wide range 
of bioactive molecules (Ivanova et al., 2005). Nitraria retusa is one of the native perennial 
halophyte species that belong to the botanical family Nitrariaceae. It is distributed in North 
Africa and restricted to Algeria and Tunisia. In Tunisia, it is widespread in central and south 
parts. This salt-tolerant and drought resistant shrub grows along shallow and hummocks on 
saline grounds near the coastal areas and produces fleshy red fruits from which a tasty and 
refreshing juice may be extracted. Nitraria retusa is known in Tunisia as “Ghardaq”. The sweet 
drupes are edible and for the treatment of hypertension. Leaves infusion and decoction are used 
as tea or cataplasm for their anti-inflammatory properties (Le Floc, 1952). In previous 
chemosystematic investigation, the flavonoids contained in Nitraria retusa leaves were studied; 
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six isorhamnetin glycosides (isorhamnetin-3-O-robinobioside, isorhamnetin-3-O-rutinoside, 
isorhamnetin-3-O-galactoside, isorhamnetin-3-O-glucoside, isorhamnetin 3-xylosylrobinobioside 
and isorhamnetin- 3-O-4-Rhamgalactosylrobinobioside) and free isorhamnetin were identified 
(El-Alali et al., 2012). These bioactives molecules isolated from Nitraria retusa have been 
reported to promote apoptosis in human myelogenous erythroleukemia cells (Boubaker et al., 
2012), and to exert antioxidant and anti-mutagenic activities (Boubaker et al., 2010). To the best 
of our knowledge, this is the first time to report the effect of Nitraria retusa ethanol extract 
(NRE) reducing body weight in mice fed with high-fat diet in correlation with lipid metabolism 
in liver. 
3.2. Materials and Methods 
3.2.1. Plant sampling 
Nitraria retusa shoots were collected during August 2010 from the salt flat “Sabkha El kelbia” 
located at N 35 48 44, E 10 09 06 (Kairouan, Tunisia). This locality is characterized by a semi-
arid climate with less rainfall < 200 mm/year and higher soil salinity (20 g/L). The collected 
samples were rinsed with distilled water, kept in laboratory temperature; oven dried at 60°C and 
then ground finely using a ball mill type “Dangoumeau”. The plant powder obtained was stored 
at room temperature for further experiments. 
3.2.2. Extraction methods 
Seventy percent ethanol extraction Nitraria retusa sample was conducted with 10% (w/v). The 
ethanol extract was kept in the dark at room temperature for 2 weeks, with shaking at least once 
a day. The liquid fraction was then collected, filtered through 0.22 μm filter (MILLIPORE, 
U.S.A.), and concentrated using SpeedVac (SCRUM Inc., Japan). The dried residue was re-
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dissolved in seventy percent ethanol or milliQ by vortexing and stored at -80°C for further 
experiments. 
3.2.3. Animals and experimental design  
Four-weeks-old, male C57B6/JL mice, were purchased from Charles River (Japan) and were 
maintained under a light cycle (12 h light/dark), fed with a high fat diet (HFD) or a normal diet 
(ND), purchased from Oriental Yeast Company (Japan) and according to the composition 
described in Table 3. 1.. After 1 week acclimatization, mice were divided randomly to 5 groups 
with 8 individuals for each group; Control normal diet group (CND) fed with normal diet and 
orally administrated with water as vehicle, control high-fat diet group fed with HFD and orally 
administrated with water as vehicle (CHFD), High fat diet group fed with HFD and orally 
administrated with naringenin as positive control well known for its activity in vivo assays, 
especially by amelioration of hepatic steatosis and attenuation of dislypedimia without affecting 
caloric absorption in fat-fed C57B6J/L mice (Mulvihill et al., 2009) at a dose of 10 mg/kg of 
body weight (HFD+PC), high-fat diet group fed with HFD and orally administrated with 
Nitraria retusa extract at 50 mg/kg of body weight (HFD+NR50) and high-fat diet group fed 
with HFD and orally administrated with NRE at 100 mg/kg of body weight (HFD+NR100). 
Body weight and food intakes were measured daily at regular intervals during the feeding period 
(28 days). Following 4 weeks treatment, animals were sacrificed. Blood samples were collected, 
liver and fat tissue were dissected, weighed and kept at -80°C until use. All procedures were 
performed in accordance with the Ethics Animal Care and Use Committee of the University of 
Tsukuba, Japan. 
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3.2.4. Biochemical analysis of blood serum  
Collected blood samples were centrifuged at 2,000×g for 15 min at 4°C. Then several 
metabolites like: serum glucose, triglyceride (TG), total cholesterol (TCHO), high-density 
lipoprotein (HDL) and low-density lipoprotein (LDL) levels were measured according to the kit 
manufacturer’s instruction. The cytokine tumor necrosis factor-alpha (TNF-α) level in serum was 
also analyzed using the Enzyme Linked-Immuno-Sorbent Assay (ELISA) (Invitrogen Ms TNF-α 
kit) according to manufacturer's instructions. 
3.2.5. RNA isolation from liver and real-time-PCR analysis 
Fifty mg liver samples were homogenized using Polytron® PT 1200 E homogenizer 
(Switzerland). Then total RNA was purified using the ISOGEN kit (Nippon GeneCo. Ltd., 
Japan) following the manufacturer’s instructions. Total RNA was quantified and quality-checked 
using Thermo scientific Nanodrop 2000 (USA) and the reverse transcription reactions were 
performed using the Superscript III reverse transcriptase kit (Invitrogen, Carlsbad/CA, USA) 
using 1 μg of total RNA. Briefly, RNA was denatured by incubation at 65°C for 5 min, with 1 
μL oligo (dT) primers, and chilled at 4°C. Then SuperScript III reverse transcriptase was added 
and the reaction mix was then incubated at 42°C for 60 min, then 10 min at 70°C (Han and 
Isoda, 2009). The gene expression of Peroxisome Proliferator-Activated Receptor Gamma 1 
(PPAR-γ 1), Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α), Lipoprotein Lipase 
(LPL), Fatty Acid Synthase (FAS), Acetyl-CoA Carboxylase 1 (ACC1) and Carnitine palmitoyl 
transferase I (CPT1) were determined by real-time PCR, normalized to beta-actin and reported as 
fold of control. Primers and TaqMan probes used for these experiments were purchased from 
Applied Biosystems. Primers were inventoried gene expression assays. TaqMan real-time PCR 
amplification reactions were performed in a 20 μL reaction mixtures containing: 10 μL of 
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TaqMan Universal PCR Master Mix UNG (2X), 9 μL of template cDNA (100 ng /μL) and 1 μL 
of the corresponding primer/probe mix, using an AB 7500 fast real-time system (Applied 
Biosystems). For the amplification, the following cycling conditions were applied: 2 min at 
50°C, 10 min at 95°C, and 40 cycles of 15 s at 95 °C / 1 min at 60°C. 
3.2.6. Statistical analysis 
All experiments were repeated at least three times. Data were expressed as the mean ± SD or the 
mean ± SEM. Differences between control and treatments were assessed by Student’s unpaired t-
test. P values below 0.05, 0.01, and 0.001 were considered significant. 
3.3. Results 
3.3.1. Anti-obesity effects of NRE in HFD-induced C57B6J/L obese mice 
As shown in Fig. 3. 1., the HFD increased body weight gain significantly compared to ND over 
4 weeks treatment period in C57B6J/L mice. Moreover, final body weight was significantly 
lower in the HFD+NR50 (24.60 ±0.50 g) and HFD+NR100 (24.40 ± 0.70 g) groups compared to 
CHFD group (27.62 ± 0.50 g) (Table 3. 2.) (p<0.05), without affecting food intake, which was 
around 3g/day/mice for all different experimental groups (Table 3. 3.). It is well known that, 
body weight and fat stores are determined by the net excess or deficit of food intake over energy 
expenditure. In the current study, NRE treatment was demonstrated not only to decrease 
cumulative body weight gain, but also adipose tissue weight and improve adiposity index. In fact 
50 mg/kg BW and 100 mg/kg BW NRE treatment in HFD mice decreased adipose tissue weight 
from 1.80 ± 0.20 g in vehicle group to 1.10 ± 0.21 g and 1.20 ± 0.16 g, respectively (Fig. 3. 2.). 
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3.3.2. Effect of NRE administration on glucose, triglycerides, cholesterol and TNF-α in 
HFD-induced C57B6/JL obese mice 
Serum glucose and lipid levels (triglycerides, total cholesterol, HDL-cholesterol (HDL-c), LDL-
cholesterol (LDL-c)) and also the cytokine TNF-α level of all mice groups were analyzed.  
Results are summarized in Table 3. 4.. The HFD-fed mice showed significant high levels of 
serum glucose (200.00 ± 4.10 mg/dL), triglycerides (22.00 ± 1.63 mg/dL) and higher level of 
HDL-c (80.00 ± 1.55 mg/dL) when compared to those fed with normal diet (CND group). As 
shown in Table 3. 4., 50 mg/kg and 100 mg/kg NRE and naringenin (positive control) treatments 
significantly decreased glucose levels in blood serum of HFD-fed mice to reach 168.00 ± 2.69 
mg/dL, 153.00 ± 9.41 mg/dL, and 146.00 ± 1.63 mg/dL, respectively. Triglycerides levels were 
also significantly decreased to 10.00 ± 1.63 mg/dL and 14.00 ± 1.63 mg/dL in 50 mg/kg and 100 
mg/kg NRE treated HFD-mice, respectively. However, naringenin treatment did not affect their 
levels. NRE administration for 4 weeks did not affect the total cholesterol in HFD-induced obese 
mice blood serum. However, it significantly increased HDL-c fraction (the good cholesterol) 
from 80.00 ± 1.55 mg/dL in vehicle group to 98.00 ± 4.10 mg/dL and 92.00 ± 4.10 mg/dL 
respectively for HFD+NR50 and HFD+100 groups (p<0.05). This cholesterol fraction in large 
numbers correlates with better health outcomes since transport cholesterol back to the liver for 
excretion. On the other hand, only 100 mg/kg NRE administration, significantly, decreased LDL-
c (the bad cholesterol) from 16.50 ± 2.03 mg/dL for vehicle group to 12.00 mg/dL (p<0.05). 
3.3.3. Effect of NRE treatment on hepatic lipid metabolism gene expression in HFD-
induced C57B6/JL obese mice 
High serum lipid level mainly triglycerides and cholesterol are a hallmark of many metabolic 
syndrome diseases such as type 2 diabetes. Understanding the molecular mechanism that 
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undergoes dyslipidemia should facilitate improved strategies for serum lipid management. In this 
respect, the effect of NRE administration in HFD-induced mice on hepatic lipid metabolism 
biomarkers at translational level was investigated, following 4 weeks experimental study. In fact, 
50 mg/kg BW and 100 mg /kg BW NRE treatments significantly increased the gene expression 
of the hepatic PPAR- γ1 (Fig. 3. 3. a.) to 6 and 4 folds, respectively. While, only 50 mg/kg BW 
NRE dose improved PPAR-α gene expression (Fig. 3. 3. b.) by 2 folds. Moreover, NRE 
treatments significantly modulated the lipogenic enzyme genes ACC1 and FAS. In fact, FAS 
gene expression was decreased by half at 100 mg/kg BW dose (Fig. 3. 4. a.), and ACC1 gene 
expression was increased by 2.5 folds at 50 mg/kg BW dose (Fig. 3. 4. b.). Additionally, 50 
mg/kg NRE treatment in HFD-induced obese C57BL/6J mice significantly increased CPT1 (Fig. 
3. 5.) and LPL (Fig. 3. 6.) genes expression to reach 6 and 30 folds respectively. These results 
were concordant with weight loss, adiposity index and biochemical metabolites investigation. 
The current data indicates that in vivo administration of NRE could be an effective plant 
preparation in enhancing liver lipid metabolism and preventing obesity. 
3.4. Discussion 
In the current study, NRE administration in HFD-induced obese C57BL/6J mice for 4 
consecutive weeks, significantly reduced body weight gain and adipose tissue accumulation 
without affecting food intake. Furthermore, these effects were in concordance with a significant 
improvement of glucose and lipid metabolism in blood serum and the expression profiles of 
genes related to beta-oxidation, lipolysis and lipogenesis in the liver. These findings 
demonstrated that NRE suppresses obesity in HFD-induced obese mice. It is well known that 
obesity is caused by imbalanced homeostasis between low energy expenditure and increased 
energy intake and accumulation (Galgani and Ravussin, 2010). Excess energy is mainly stored as 
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triglycerides in adipose tissue which increase the visceral adipose tissue mass through adipocyte 
hypertrophy and hyperplasia (Hajer et al., 2008). Several strategies are proposed to reduce or 
suppress obesity, among them dietary supplements and natural products (Chandrasekaran et al., 
2012). In fact, herbal and botanical preparations are gaining a lot of interest either to substitute 
chemical drugs or to be combined with them. In this respect, Nitraria retusa, an edible halophyte 
plant growing wild in Tunisia, could be a potent candidate. Previous phytochemical studies from 
our research and others demonstrated that Nitraria retusa has a strong anti-oxidant and free 
radical scavenging properties due mainly to its high contents in polyophenols and flavonoids 
(Hadj Salem et al., 2011). The HPLC analysis showed the presence of several alkaloids like 5, 7-
dihydroxy-3-deoxy-vasiciene I, 7-hydroxy-3-deoxy1-vasiciene II and O-acetylnitraraine I (El-
Alali et al., 2012). The phenolic profile showed mainly, high contents of isorhamnetin aglycone 
and glycosides (Sameh et al., 2009) and other flavonoids like apigenin, quercetin, kaempherol 
and luteolin (Pandey and Rizvi, 2009). The high content in flavonoids and their possible 
synergetic effect may explain in part the anti-obesity effect of NRE, since these compounds were 
individually demonstrated to have high potential to prevent metabolic syndrome diseases (Hsu 
and Yen, 2006), and their mixture showed synergetic anti-obesity effect (Yang et al., 2008; 
Aguirre et al., 2011; De Santi et al., 2000; Liang et al., 2003). The investigation of biochemical 
markers like glucose, total triglycerides, total cholesterol, LDL, HDL, and TNF α in mice blood 
serum, demonstrated that NRE significantly improved these parameters except for TNFα and 
overall data showed higher activity than naringenin, commonly used as positive control. In 
general, the accumulation of triglycerides in the liver is due to an imbalance between the 
availability of hepatic triglycerides for export and the exporting capacity of the liver via very 
low-density lipoproteins (VLDLs) (Tirosh et al., 2008). Furthermore, in the liver cells an 
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increase in glucose exerts, both directly and indirectly, a series of effects which result in the 
orientation of its metabolism towards glycogen synthesis, glycolysis and formation of fatty acids 
(Van Den Berghe, 1991). On the one hand a first direct effect of glucose is to stimulate its 
hepatic uptake which could be ameliorated with NRE activity on the lowering effect of the serum 
glucose level. On the other hand, an increase in triglycerides levels, particularly when 
accompanied by a decrease in high-density lipoprotein (HDL) levels, has been shown to be a 
surrogate marker of insulin resistance, a strong predisposing condition for type-2-diabetes 
(Mulvihill et al., 2009). Lipids and carbohydrates metabolism in liver is controlled by several 
genes. In this respect, the investigations of NRE treatment in HFD-induced obese mice on 
hepatic genes related to beta-oxidation, lipolysis and lipogenesis, showed a significant 
improvement of their expression when compared to vehicle group or naringenin treatment 
leading to a control effect of weight gain and fat mass. However, naringenin was reported to 
ameliorate hepatic steatosis and attenuate dyslipidemia, without affecting caloric absorption 
(Hajer et al., 2008), with an improvement of hepatic fatty-acid oxidation through PPAR-α 
coactivator 1 alpha. This study is very concordant with our current results revealing that 
naringenin could regulate some gene expressions related to lipid metabolism (Fig. 3. 3., Fig. 3. 4. 
and Fig. 3. 5.) and ameliorate the serum lipid profile (Table 3. 4.) of mice fed a high fat diet but 
without any suppression effect on body weight gain (Fig. 3. 1. and Table 3. 2.). Fatty acid 
metabolism in the liver involves three main pathways; catabolism by β-oxidation, synthesis, from 
acetyl CoA and esterification into triglycerides. Herein in our study, NRE administration in 
HFD- fed mice significantly over-expressed PPAR-α by 2 folds increase and promoted fatty acid 
β-oxidation via overexpression of CPT1 gene, by 6 folds. In fact, PPAR-α are homogenous group 
of genes that participate in lipid catabolism such as fatty acid uptake through membrane, fatty 
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acid binding in cells, fatty acid oxidation and lipoprotein assembly and transport (Hihi et al., 
2002). PPAR-γ1 are known to influence the storage of fatty acids in the adipose tissue (Maglich 
et al., 2009), but its mRNA expression is detected at lower level in liver. This in turn could be 
one of other factors (period of high-fat diet feeding, etc…) affecting its expression in liver of 
mice fed with HFD compared to those fed with ND (Fig. 3. 3. a.). PPAR-α activation is known 
to mediate the expression of genes promoting fatty acid β-oxidation mainly CPT1 gene which is 
the encoding gene of carnitine palmitoyltransferase system which is a critical and essential step 
in the β-oxidation of long chain fatty acids (Flanagan et al., 2010). Such cascade of molecular 
events will lead finally to lowering the circulating fatty acids and triglycerides-rich-lipoproteins 
(Wakil et al., 2009). Furthermore, NRE administration in HFD-fed mice significantly increased 
ACC1 gene expression encoding for the lipogenic enzyme Acetyl-CoA Carboxylase which is an 
attractive target for therapeutic in the control of obesity (Yamamoto et al., 1995). However, NRE 
administration slightly decreased FAS gene expression encoding for the fatty acid synthase at 50 
mg/kg dose. Such effect demonstrates that NRE administration might not negatively affect the 
fatty acid metabolism since there was an enhancement of CPT1 expression in the liver of NRE-
treated mice. In our case, gene expressions of lipogenic enzymes were analyzed after an 
experimental period of 4 weeks. It was already known that, FAS gene expression could be 
influenced by the period of high-fat diet feeding. Actually, there is a difference on its expression 
depending on the short term or long term of feeding. Actually, in 1 week and 2 weeks FAS gene 
expression could increase but in long term feeding, an adaptation to excess fat accumulation will 
occur and β-oxidation rate will increase. Thus, FAS expression will decrease or return to normal 
level as control (Nishikawa et al., 2012). Concerning the gene expression of LPL that encodes 
the enzyme responsible for the hydrolysis of triglycerides in lipoproteins, and its effect on the 
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plasma cholesterol level. Results showed that the oral administration of NRE in mice fed with 
high fat diet had a highly significant overexpression of LPL more than 30 fold. In this regard, it 
has been demonstrated that LPL overexpression prevents the development of diet-induced 
hypertriglyceridemia and hypercholesterolemia and decreases VLDL and LDL fractions levels in 
LPL transgenic mice after cholesterol loading (Wang and Eckel, 2009). These findings suggest 
that LPL plays an important role in determining cholesterol levels. Furthermore, it has been also 
highlighted that free fatty acids uptake into adipocytes is also facilitated by the extracellular 
expression and activity of lipoprotein lipase (Wang and Eckel, 2009). LPL activity changes 
dramatically in various tissues in response to energy requirements and its systemic 
overexpression results in increases in whole body insulin sensitivity (Wang and Eckel, 2009). 
Our study demonstrated that NRE treatment in HFD fed mice significantly ameliorated the 
hepatic gene profile expression involved in lipid homeostasis. In this respect, several herbal 
preparations cited in the literature showed similar effects. Flavonoids like isorhamnetin (Lee et 
al., 2010), naringenin (Yoshida et al., 2010) and quercetin (Ahn et al., 2008), individually or 
mixed showed significant reduction in obesity and type-2-diabetes incidence. 
3.5. Conclusion 
Taken together, our results demonstrated that NRE treatment in vivo levels; exerts anti-obesity 
action through lowering glucose and triglycerides, and the enhancement of the lipid metabolism 
in liver due to the increasing of serum HDL-cholesterol, the decreasing of LDL-cholesterol 
modulating the gene expression related to lipid metabolism. This effect may be due to the 
improvement of the antioxidant status within hepatic cells by the strong antioxidant activities of 
many phenolic components present in NRE especially flavonoids such as isorhamnetin 
aglycones and glycosides. Thus, the identification of possible active compounds and 
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standardization of NRE may provide an opportunity to develop a novel class of anti-obesity 
supplement or functional food. Further investigations will be needed in order to evaluate NRE 
anti-obesity bio-active molecules efficacy and their bio-availability. 
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Table 3. 1. Composition of experimental diets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ingredient  Normal diet (ND) 
(%) 
High fat diet (HFD) 
(%) 
Casein 18.5 25.6 
L-cystine 0.28 0.36 
Maltodextrin 29.01 6.01 
α-Corn starch 9.67 16.00 
Sucrose 2.00 5.50 
Soybean oil 25.00 2.00 
Lard 2.00 33.00 
Cellulose  6.61 6.61 
Mineral mix AIN 93G 3.50 3.50 
Calcium carbonate 0.18 0.18 
Vitamin mix  AIN93 1.00 1.00 
Choline bitartrate 0.25 0.25 
Total 100 100 
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Table 3. 2. Body weight in ND, HFD, HFD+PC, HFD+NR50 and HFD+NR100 groups for 4 
weeks. 
 
 
 
Data represent the mean ± SEM, * p<0.05, when compared to the CHFD group (n=8 per group) 
CND: Control Normal diet fed group 
CHFD: Control High-fat diet fed group 
HFD+PC: High-fat diet + positive control (Naringenin 10 mg/kg body weight) 
HFD+NR50: High-fat diet + Nitraria retusa 50 mg/kg body weight 
HFD+NR100: High-fat diet+ Nitraria retusa 100 mg/kg body weight 
 
 
 
 
 
 CND CHFD HFD+PC HFD+NR50 HFD+NR100 
Body weight (g) 
Initial 19.12 ± 0.40 19.18 ± 0.30 18.93 ± 0.60 19.40 ± 0.40 19.60 ± 0.40   
 Final    23.25± 0.40* 27.62 ± 0.50 26.64 ± 0.20 24.60 ±0.50* 24.40 ±0.70* 
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 CND CHFD HFD+PC HFD+NR50 HFD+NR100 
Food intake (g) 3.25 ± 0.10 3.12 ± 0.10 3.00 ±0.10 3.25 ± 0.20 3.06 ± 0.10 
Food efficiency 
ratio (FER) 
1.26 ± 0.07 2.70 ± 0.10  2.42 ± 0.20 1.60 ±0.07*** 1.56 ± 0.10*** 
Table 3. 3. Food intake (g/day) and Food efficiency ratio (FER) in CND, CHFD, HFD+PC, 
HFD+NR50 and HFD+NR100 groups for 4 weeks 
 
 
 
 
 
 
 
 
 
Data represent the mean ± SEM, ***p<0.001, when compared to the CHFD group (n=8 per 
group) 
CND: Control Normal diet fed group 
CHFD: Control High-fat diet fed group 
HFD+PC: High-fat diet + positive control (Naringenin 10 mg/kg body weight) 
HFD+NR50: High-fat diet + Nitraria retusa 50 mg/kg body weight 
HFD+NR100: High-fat diet+ Nitraria retusa 100 mg/kg body weight 
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Table 3. 4. Blood constituents in CND, CHFD, HFD+PC, HFD+NR50 and HFD+NR100 groups 
after 4 weeks. 
 
 
 
 
 CND CHFD HFD+PC HFD+NR50 HFD+NR100 
Serum total 
cholesterol 
(mg/dL) 
134.00  ±  4.65 174.00  ±  8.64 154.00  ±  4.10 182.00  ±  1.55 170.00  ±  5.59 
Serum HDL-
cholesterol 
(mg/dL) 
66.00   ±  4.65 80.00  ±  1.55 64.00  ± 1.55** 98.00  ±  4.10* 92.00  ±  4.10 
Serum LDL-
cholesterol 
(mg/dL) 
9.00  ± 1.22 16.50  ±  2.03 6.00 ± 0.00** 18.00 ± 0.00 12.00 ± 0.00* 
Serum 
triglycerides 
 (mg/dL) 
16.00 ± 3.11 22.00 ± 1.63 22.00 ± 1.63 10.00 ± 1.63* 14.00 ± 1.63* 
Serum glucose  
 (mg/dL) 
102.00 ± 14.97 200.00 ± 4.10 146.00 ±1.63** 168.00 ± 2.69** 153.00 ± 9.41* 
Serum TNF α 
 (pg/ml) 
63.20 ± 1.40 61.08 ± 0.58 61.31 ±  0.58 64.43 ± 0.56 65.72 ±  1.22 
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Data represent the mean ± SEM, * p<0.05, **p<0.01, when compared to the CHFD group 
 (n =5 per group) 
CND: Control Normal diet fed group 
CHFD: Control High-fat diet fed group 
HFD+PC: High-fat diet + positive control (Naringenin 10 mg/kg body weight) 
HFD+NR50: High-fat diet + Nitraria retusa 50 mg/kg body weight 
HFD+NR100: High-fat diet+ Nitraria retusa 100 mg/kg body weight 
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Fig. 3. 1. Effect of daily oral administration of Nitraria retusa (50 and 100 mg/kg body weight) on 
cumulative body weight gain of mice fed with high-fat diet.  
Mice were fed normal diet (CND), High-fat diet (CHFD), high-fat diet supplemented with positive 
control Naringenin 10 mg/kg body weight (HFD+PC), ), high-fat diet supplemented with Nitraria 
retusa 50 mg/kg body weight (HFD+NR50) or high-fat diet supplemented with Nitraria retusa 100 
mg/kg body weight (HFD+NR100) for 4 weeks. Body weight was daily measured at regular time. 
Data represent mean ± SEM, n=8, * p<0.05, significant between HFD+NR50 or HFD+NR100 and 
CHFD.  
 
 
 
 
 
 
*
* 
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Fig. 3. 2. Effect of daily oral administration of Nitraria retusa (50 and 100 mg/kg body weight) on 
adipose tissue weight (a), adiposity index (b) and Fat/body weight (mg/g) ratio (c) of mice fed with 
high-fat diet.  
Mice were fed normal diet (CND), High-fat diet (CHFD), high-fat diet supplemented with positive 
control Naringenin 10 mg/kg body weight (HFD+PC), high-fat diet supplemented with Nitraria 
retusa 50 mg/kg body weight (HFD+NR50) or high-fat diet supplemented with Nitraria retusa 100 
mg/kg body weight (HFD+NR100) for 4 weeks. At the end of experiment, adipose tissue, for all 
groups, was weighed. Data represent mean ± SEM, n=8, ** p<0.01, *** p<0.001 compared to the 
high-fat diet group.  
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Fig. 3. 3. Effect of daily oral administration of Nitraria retusa (50 and 100 mg/kg body 
weight) on genes regulating lipid metabolism in liver of mice fed with high-fat diet. 
Peroxisome proliferator activated receptor gamma (PPAR-γ1) (a) and Peroxisome proliferator 
activated receptor alpha (PPAR-α) (b). Real time PCR was conducted and result was 
expressed as m RNA expression fold change compared to the control high-fat diet HFD. Bars 
represent mean ± SD. ** p<0.01, *** p<0.001, compared to the high-fat diet group.  
 
 
PPAR-γ1 PPAR-α 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. 4. Effect of daily oral administration of Nitraria retusa (50 and 100 mg/kg body 
weight) on genes regulating lipid metabolism in liver of mice fed with high-fat diet. 
Lipogenic enzymes: Fatty acid synthase (FAS) (a), and Acetyl-CoA Carboxylase1 (ACC1) 
(b). Real time PCR was conducted and result was expressed as m RNA expression fold 
change compared to the control high-fat diet HFD. Bars represent mean ± SD. * p<0.05, ** 
p<0.01, *** p<0.001, compared to the high-fat diet group.  
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Fig. 3. 5. Effect of daily oral administration of Nitraria retusa (50 and 100 mg/kg body 
weight) on genes regulating lipid metabolism in liver of mice fed with high-fat diet. Carnitine 
palmitoyltransferase I (CPT1) essential step in the beta-oxidation of long chain fatty acids. 
Real time PCR was conducted and result was expressed as m RNA expression fold change 
compared to the control high-fat diet HFD. Bars represent mean ± SD. ** p<0.01, *** 
p<0.001, compared to the high-fat diet group.  
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Fig. 3. 6. Effect of daily oral administration of Nitraria retusa (50 and 100 mg/kg body weight) on 
genes regulating lipid metabolism in liver of mice fed with high-fat diet. Lipoprotein lipase (LPL): 
enzyme responsible for the hydrolysis of triglycerides in lipoproteins. Real time PCR was conducted 
and result was expressed as mRNA expression fold change compared to the control high-fat diet 
HFD. Bars represent mean ± SD. *** p<0.001 compared to the high-fat diet group. 
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Oral administration of Nitraria retusa ethanolic extract enhances 
hepatic lipid metabolism in db/db mice model ‘BKS.Cg-Dock7
m
+/+ 
Lepr
db/
J’ through the modulation of lipogenesis- lipolysis balance 
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4.1. Introduction 
Prevention and treatment of obesity and obesity-related diseases are an important deal for health 
systems. The main target of many in vivo studies and clinical trials, is to reduce  fat mass and 
overweight prevealence, and related health problems over the world (Ranjbar et al., 2013). 
Obesity and being overweight are problems of growing importance, being an essential risk factor 
for type-2 diabetes, when accompanied with other known complications. Therefore, it has been 
an important therapeutic goal to reduce the risk of type-2-diabetes through weight management 
(Yumuk et al., 2014). In order to improve our knowledge concerning the pathological 
mechanisms of human obesity disease, good animal models are very helpful. In this context, 
several mice models of obesity are used in the research of obesity-related human health 
symptoms and metabolic disorders mainly diabetes. The db/db mice model BKS.Cg-Dock7
m
+/+ 
Lepr
db/
J are mice homozygous for the diabetes spontaneous mutation (Lepr
db
) which become 
obese at approximately three to four weeks of age. Homozygous mutant mice are polyphagic, 
polydipsic, and polyuric (Lutz and Woods, 2012). At one month of age, db/db mice are larger 
(obese) presenting increased fat deposition in the inguinal and axillary regions when compared to 
control (heterozygous) littermates (Lee et al., 1996). Different methods have been used to reduce 
body weight and its complications for many years. Herbal medicines have been in consideration 
as a current alternative to reduce body weight gain and fat mass, for example, Nigella sativa, 
Camellia synensis, green tea, and black Chinese tea were found to possess effective anti-obesity 
actions resulting in a potential management of other health disorders related to obesity, mainly 
cardiovascular diseases and diabetes (Ranjbar et al., 2013). The mechanisms whereby bioactives 
molecules affect body weight and body composition may include modifications in appetite 
control, enhancement of hepatic lipid metabolism and decreased food intake (Rainsa et al., 
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2011). The most common complementary and alternative medicine modalities are based in food 
supplements and herbal therapies. In this regard, many crude extracts of plants and their isolated 
bioactive compounds were shown to be effective in prevention and treatment of obesity by either 
inducing weight loss or preventing weight gain (Ranjbar et al., 2013). Halophytes, salt-tolerant 
species, are considered a potent source of various chemical secondary components with a big 
economic interest (Ksouri et al., 2011). Compared to the glycophytic species, halophytes contain 
much higher amounts of secondary metabolites or even restricted to halophytic species which 
could be used in various application fields such as pharmacognosy and functional foods 
(Boughalleb and Denden., 2011). The biological function of bioactive-compounds might be 
single, or combined with others present in  whole plant extracts mixtures leading to synergistic 
effect and depending on its chemical composition and efficacy (Buhmann and Papenbrock, 
2013). Until present, several potential applications of halophytes are still in the research and 
development phase (Atia et al., 2011). The genus Nitraria is an edible halophyte shrub well 
adapted to arid climate; species of Nitraria are found in desert as well as in salty regions. 
Nitraria retusa Forssk is known in Tunisia as “Ghardaq”. Fruits of Nitraria species have been 
used as nutritional food and traditional herb for the treatment of hypertension and abnormal 
menstruation (Hadj Salem et al., 2011). The leaves serve as supplement for tea and are used as 
poultice. The ashes of this species have the ability to remove fluids of infected wounds. Fresh 
leaves of Nitraria retusa decoction is used in Morocco in case of poisoning, upset stomach, 
ulcers, gastritis, colitis and colonic abdominal pain (Boubaker et al., 2010). Prevention and 
controlling weight gain effect of Nitraria retusa ethanolic extract (NRE) was investigated in our 
previous study using high fat diet-induced obesity experiment in C57B6J/L mice. Nonetheless, it 
is unknown whether NRE is effective in reducing weight gain in transgenic db/db mice with 
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spontaneous diabetes, or in the enhancement of lipid metabolism in the liver and generally is 
effective in treating or ameliorating obesity in this monogenic model of mice. Our findings, 
which focus on both safety and efficacy of in vivo NRE oral administration, could be useful for 
further pharmaceutical or industrial applications to find a mixture of NRE components with 
higher efficacy of the anti-obesity agents. 
4.2. Materials and Methods 
4.2.1. Plant sampling 
The halophytic species Nitraria retusa was selected in this study. Shoots collect was conducted 
in August 2010 from salt flat “Sabkha Elkelbia” located at N ‘35 48 44’, E ‘10 09 06’ of 
Kairouan. This locality is characterized by a semi-arid climate with less rainfall < 200 mm/year 
and higher salinity mean (20g/L). The collected samples were rinsed with distilled water, kept in 
laboratory temperature; oven dried at 60°C and then ground finely using a ball mill type 
“Dangoumeau”. The plant powder obtained was stored at room temperature for different 
analysis. 
4.2.2. The preparation of Nitraria retusa extract for animal experiment 
 
Seventy percent ethanol extraction of Nitraria retusa powder sample was conducted with 10% 
(w/v). The ethanol extract was kept in dark at room temperature for 2 weeks, with shaking at 
least once a day. After centrifugation of the mixture, liquid fraction was then collected, filtred 
through 0.45 μm filter (MILLIPORE, U.S.A), and concentrated using SpeedVac (SCRUM Inc., 
Japan). Finally it was dissolved in MilliQ water depending on the determined dose selected for 
oral administration.  
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4.2.3. Animals and experimental design 
Five-week-old, male BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/db) mice and their litter mates (db/+) 
were purchased from Charles River and maintained under a light cycle (12h light/dark), fed with 
a diet contained 3.13 Kcal/g with 10.5% calories from fat, 25% from protein and 64.5 % from 
carbohydrates purchased from  PMI Nutrition International . The animals were allowed 1 week 
to acclimatize themselves to the housing conditions before the beginning of the experiment. Then 
mice were randomly divided into 4 groups, 2 groups; db/db mice control and db/db mice NRE; 
were orally administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) 
respectively. Their two litter mates groups; db/
+ 
(lean mice) control and db/
+
 (lean mice) NRE 
were also orally administrated with the same doses as described above. Food consumption and 
weight gain were measured daily and weekly at regular times. At the end of experimental period 
(4 weeks), mice were sacrificed; organs were removed after collecting blood for analysis, rinsed 
with a physiological saline solution and immediately stored at -80ºC. All procedures were 
performed in accordance with the Ethics Animal Care and Use Committee of the University of 
Tsukuba, Japan. 
4.2.4. Measurements of body and fat weights 
Body weight was measured once a day during the feeding period. Internal organs were dissected, 
weighed and then, stored until they were analyzed for further experiments. 
4.2.5. Measurements of glucose, triglyceride and cholesterol levels 
After 4 weeks of treatment, blood samples were collected and centrifuged at 2,000×g for 15 min 
at 4ºC, and serum glucose, triglycerides (TG), total cholesterol (TCHO), high-density lipoprotein 
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(HDL) and low-density lipoprotein (LDL) levels were measured according to the kit 
manufacturer’s instruction. 
4.2.6. RNA isolation from organs liver and real-time-PCR analysis 
Liver samples were prepared (50 mg) and homogenized with a Polytron homogenizer. Then total 
RNA was purified using the ISOGEN kit (Nippon GeneCo. Ltd., Japan) following the 
manufacturer’s instructions. Total RNA was quantified using Thermo scientific Nanodrop 2000 
(USA), and the reverse transcription reactions were performed using the Superscript III reverse 
transcriptase kit (Invitrogen, Carlsbad/CA, USA) using 1 µg of total RNA. Briefly, RNA was 
denatured by incubation at 65°C for 5 min, with 1 µL oligo (dT) primers, and chilled at 4°C. 
Then SuperScript III reverse transcriptase was added and the reaction mix was then incubated at 
42°C for 60 min, then 10 min at 70°C (Han and Isoda, 2009). The expression of Peroxisome 
proliferator-activated receptor gamma (PPAR-γ1), Peroxisome proliferator-activated receptor 
alpha (PPAR-α) , Lipoprotein lipase (LPL), Fatty acid synthase (FAS), Acetyl-CoA –
Carboxylase 1 (ACC1), Sterol regulatory element-binding protein 1-c (SREBP-1-c) and Carnitine 
palmitoyl-transferase 1 (CPT-1); were determined by real-time PCR using Beta –actin as 
housekeeping gene. Primers and TaqMan probes used for these experiments were purchased 
from Applied Bio-systems. Primers were inventoried gene expression assays. TaqMan real-time 
PCR amplification reactions were performed in a 20 µL reaction mixtures containing: 10 µl of 
TaqMan Universal PCR Master Mix UNG (2X), 9 µL of template c-DNA (100 ng µL
-1
) and 1 
µL of the corresponding primer/probe mix, using an AB 7500 fast real-time system (Applied 
Bio-systems). For the amplification, the following cycling conditions were applied: 2 min at 
50°C, 10 min at 95°C, and 40 cycles of 15 s at 95 °C / 1 min at 60°C. 
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4.2.7. Statistical analysis 
All experiments were repeated at least three times. Data were expressed as the mean ± SD or the 
mean ± SEM. Differences between control and treatments were assessed by Student’s unpaired t-
test. P values below 0.05, 0.01, and 0.001 were considered significant.  
4.3. Results 
4.3.1. NRE administration reduces body weight gain as well as adipose tissue weight in 
db/db obese mice model BKS.Cg-Dock7m+/+ Leprdb/J without affecting appetite 
As shown in Fig. 4. 1., the control db/db increased body weight gain significantly compared to 
NRE db/db over 4 weeks treatment period in BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice. Moreover, final 
body weight was significantly lower in the NRE db/db (34.83 ±1.75 g) group compared to 
control db/db group (42.16 ± 2.56 g) (Table 4. 1.) (p<0.05), without affecting food intake, which 
was around 6g/day/mice for all different experimental groups (Table 4. 2.). In the current study, 
NRE treatment was demonstrated not only to decrease final body weight, but also cumulative 
body weight (Table 4. 1.) and adipose tissue weight leading to an improvement of adiposity. In 
fact 50 mg/kg NRE treatment in db/db mice decreased adipose tissue weight from 5.41 ± 0.8 g to 
2.83 ± 0.7 in db/db control group (Fig. 4. 2.). However, NRE treatment did affect neither the 
body weight nor the adiposity in lean mice group. 
4.3.2. NRE administration ameliorates lipid serum profile in db/db obese mice model 
BKS.Cg-Dock7
m
+/+ Lepr
db/
J 
Serum glucose and lipid levels (triglycerides, total cholesterol, HDL-cholesterol (HDL-c), LDL-
cholesterol (LDL-c)) of all mice groups were analyzed.  Results are summarized in Fig. 4. 3. An 
increase in triglyceride levels, particularly when accompanied by decreased high-density 
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lipoprotein (HDL) levels, has been shown to be a surrogate marker for insulin resistance, a 
strong predisposing condition for Type 2 diabetes. Thus, the in vivo effects of Nitraria retusa 
extracts, on cholesterol levels (total, low-density lipoprotein (LDL) cholesterol, and HDL 
cholesterol) was assayed.  As shown in Fig. 4. 3. A1. and C1., oral administration of a Nitraria 
retusa extract did not reduce levels of total cholesterol or levels of HDL cholesterol (the “good 
cholesterol”).  However, as shown in Fig. 4. 3. B1., oral administration of a Nitraria retusa 
extract significantly reduced LDL cholesterol (the “bad cholesterol”) levels in diabetic mice 
model by 50 % approximately, compared to the control. Regarding triglycerides and glucose 
measurement results shown in Fig. 4. 3. D1. and E1., triglycerides level was slightly decreased 
from 23.75 ± 3.80 in db/db mice control to 15.00 ± 2.89 in db/db NRE-treated mice, while 
glucose level was not significantly affected by NRE administration for 4 weeks of treatment.  
This is likely may due to the duration of the disclosed experiments. Taken together, these data 
indicate that in vivo administration of a Nitraria retusa extract is effective in reducing diabetic 
hypercholesterolemia. 
4.3.3. Effect of NRE administration on genes expression related to hepatic lipid metabolism 
which modulate lipolysis-lipogenesis balance in db/db obese mice model 
Understanding the molecular mechanism that undergoes dyslipidemia should facilitate improved 
strategies for serum lipid management. In this respect, the effect of NRE administration in 
BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice on hepatic lipid metabolism biomarkers at transcriptional 
level was investigated, following 30 days experimental study. Peroxisomes Proliferator-
Activated Receptor (PPAR-α) and PPAR- γ1, acts as a master regulator of fatty acid oxidation 
and lipid storage, respectively. Sterol Regulatory Element Binding Protein-1c (SREBP-1c) is a 
transcription factor that controls genes involved in cholesterol uptake and biosynthesis.  FAS and 
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ACC1 are two main lipogenic enzymes and are strongly correlated with insulin sensitivity. CPT1 
is the encoding gene of carnitine palmitoyl-transferase system which is an essential step in the β-
oxidation of long chain fatty acids. LPL gene encodes the enzyme responsible for the hydrolysis 
of triglycerides in lipoproteins. To assay the in vivo effects of Nitraria retusa extracts on these 
genes which regulate lipid homeostasis, Nitraria retusa extracts were administrated orally and 
daily to mice during 4 weeks and expression of said genes in liver of all groups of mice were 
determined by real-time PCR. As shown in Fig. 4. 4. to 4. 6., oral administration of Nitraria 
retusa extract significantly over-expressed expression of PPAR-γ, PPAR-α, ACC1, FAS,  
SREBP-1c, LPL as well as CPT1 genes ; in diabetic mice models. These results were concordant 
with weight loss, adiposity and biochemical metabolites investigation. The current data indicates 
that in vivo administration of NRE could be an effective plant preparation in enhancing liver 
lipid metabolism which treats or ameliorates obesity. 
4.4. Discussion 
Our previous in vivo anti-obesity study (done in chapter 3), was conducted in mice fed with high-
fat diet-induced obesity and daily administrated with Nitraria retusa extracts at final doses (50 
mg/kg BW and 100 mg/kg BW) for a period of 4 weeks. Main results revealed that oral 
administration of this extract was effective to control the weight gain and reduce significantly the 
cumulative body weight and fat mass compared to mice fed only with high-fat diet (HFD) (Zar 
kalai et al., 2013). In this current study our objective was to test whether the NRE could also 
attenuate the metabolic complications related to spontaneous obesity, using a Lepr
db
/Lepr
db 
mice 
which is a model of obesity and type-2-diabetes that is deficient in leptin receptor activity due to 
a mutation in leptin receptor (db) gene. Therefore, the anti-obesity effects of NRE were 
investigated by evaluating body weight gain and feed intake, white adipose tissue weight. Then, 
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by measuring lipid and glucose concentrations in serum, as well as mRNA expressions of genes 
related to lipogenesis-lypolysis balance in liver of transgenic db/db obese mice model BKS.Cg-
Dock7
m
+/+ Lepr
db/
J for a treatment period of 4 weeks. We used NRE at a dose of 50 mg/kg BW, 
which was a minimal effective dose in our previous study on HFD-induced obesity experiment 
(Zar kalai et al., 2013), to evaluate its oral administration effect on db/db mice model used in 
present study. Thus, supplementation with NRE significantly reduced body weight and white 
adipose tissue mass, without affecting feed intake. However, in many previous studies, some 
medicinal plants possessed anti-obesity actions through several mechanisms either by preventing 
weight gain or promoting weight loss, accompanying with appetite suppression (Sahib et al., 
2012). In other hand, it was reported that the anti-obesity activity could be ameliorated by the 
synergistic effect of a combination of some components present in a plant extract resulting in the 
enhancement of the herbal medicine’s therapeutic activity (Rayalam et al., 2011).  Although not 
bound by theory, the Nitraria retusa extracts disclosed herein likely have superior anti-obesity 
activity which could be due to synergy brought by the combination of compounds included in an 
extract. Nitraria retusa extract disclosed herein is likely rich in naturally present flavonoids 
especially glycosides ones such as; Isorhamnetin-3-O-glucoside, Isorhamnetin-3-O-rutinoside, 
and Isorhamnetin-3-O-robinobioside, quercetin and others, that could work all in synergy (Hadj 
Salem et al., 2011; Hussein et al., 2009; Boubaker et al., 2012). The whole extract mixture of 
NRE could also significantly reduced LDL cholesterol (the “bad cholesterol”) and triglycerides 
levels in diabetic mice model (Fig. 4. 3. B1. and D1.). In this respect, previous studies reported 
that the increased of plasma total cholesterol and LDL cholesterol levels are caused by diabetic 
dyslipidemia (Dokken, 2008). NRE treated db/db mice group had significantly lower levels of 
plasma LDL cholesterol when compared to control group (Fig. 4. 3. B1.). Thus, NRE treatment 
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might reduce the risk of diabetic hypercholesterolemia. Furthermore, in obesity and diabetes, the 
amounts of hepatic triglycerides available for export are increased which leads to an imbalance 
between the availability of hepatic triglycerides for export and the exporting capacity of the liver 
(Nguyen et al., 2008). However, treated db/db mice group revealed a lower level of triglycerides 
compared to control group (Fig. 4. 3. D1.) which reflect the enhancement of the lipid metabolism 
in liver. Liver occupies a central position in the metabolic homeostasis; it plays an essential role 
in oxidizing triglycerides to produce energy not only to meet its own needs, but also to cover 
those of other tissues (Nguyen et al., 2008). Eventually, in obesity the accumulation of lipids into 
hepatocytes leads to many metabolic complications due mainly to the alteration of the expression 
of many genes (PPAR-γ, PPAR-α, FAS, LPL, SREBP-1c, and CPT-1) related to lipid and 
cholesterol metabolism. Therefore, evaluating the effect of NRE exposure on the said genes 
regulating the hepatic lipid metabolism in mice model used was conducted. Generally, hepatic 
lipid metabolism is controlled by a balance between lipogenesis and lipolysis processes. This 
balance is maintained by determined level of the encoded genes expressions of lipogenic and 
lipolytic enzymes. Peroxisome Proliferator-Activated Receptors (PPARs) are ligand-activated 
transcription factors and members of the nuclear hormone receptor superfamily, which regulate 
energy homeostasis, inflammation, proliferation and differentiation (Varga et al., 2011). PPAR-γ 
promotes adipocyte differentiation and lipid storage, while PPAR-α play a main role in the 
regulation of fatty acid oxidation (Abbott, 2009), especially in tissues with high lipid catabolic 
capacities, such as the liver (Ribet and Langin, 2010).  Our findings revealed that the genes 
expressions of these two later main transcription factors were overexpressed in db/db treated 
mice compared to the control group (Fig. 4. 4. A1. and B1.), which probably reflect the effect on 
serum lipid profile. The results were concordant with those reported in previous clinical studies 
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describing that the activation of PPARα enhanced fatty acid oxidation in liver and decreased the 
levels of circulating and cellular lipids in obese diabetic patients (Kim and Kawada, 2012). The 
genes FAS and ACC1 involved in lipogenic pathway and regulating by PPAR-γ were also 
overexpressed (Fig. 4. 5. A1. and B1.) in db/db mice by NRE administration. The level of these 
enzymes involved in lipogenesis, were reported to be maintained and controlled by the SREBP-
1c, the main regulator of hepatic cholesterol homeostasis (Deng and Elam, 2012). Its hepatic 
overexpression in diabetic mice was reported to induce lipogenic enzymes leading to a marked 
decrease in hyperglycemia (Becard et al., 2001), which is in turn positively correlated with our 
results shown in (Fig. 4. 3. D1., 4. 5. A1., 4. 5. B1. and 4. 6. A1.). Moreover, it has been known 
that high FAS gene expression was correlated with insulin sensitivity in normal conditions 
conversely to db/db mice which have a low FAS gene expression caused by especially 
hyperphagia and insulin resistance (Lan et al., 2003). NRE administration could enhance the 
expression level of FAS gene in only db/db mice having the metabolic complications described 
above. The level of gene expression encoding another important lipogenic enzyme, lipoprotein 
lipase (LPL), playing a central role in fat mobilization and regulating the plasma triglycerides 
and cholesterol levels, was also overexpressed in db/db mice due to the NRE oral administration. 
Its overexpression was reported to prevent hypertriglyceridemia and hypercholesterolemia 
especially LDL levels (Yamamoto et al., 1995). These described results strongly confirm our 
findings related to the expression of hepatic LPL gene due to NRE exposure. In order to maintain 
the balance of lipid metabolism in liver between fat storage (lipogenic pathway) and fat burning, 
(lipolytic pathway), the mitochondrial fatty acid oxidation which is controlled by PPAR-α plays 
a crucial function. Carnitine palmitoyltransferase- 1 (CPT-1) is one of main target enzymes of 
PPAR-α, contribute the transport of activated long-chain fatty acids from the cytosol to the 
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mitochondrial matrix, where β-oxidation is occurring (Koo et al., 2008). The lack of carnitine 
will slow oxidation of fatty acids and fuel and increase in serum lipid level (Park et al., 2008). 
NRE oral administration in the present study up-regulates CPT1 gene expression (Fig. 4. 6. C1.), 
which could in turn clearly affects the plasma lipid levels and reduce finally the body weight 
gain in db/db mice. However, normal mice or lean mice NRE-treated groups were not affected 
by NRE administration either in body weight gain or in serum lipid profile correlated with 
hepatic genes expression described in all results. These findings could probably reflect the safety 
of the combined effect of NRE components as well as the difference in leptin signaling role 
between db/db mice and normal mice. In normal conditions, leptin signaling was reported to be 
an important mediator of feeding behavior, energy homeostasis as we as another crucial roles 
such as in immune and reproductive functions (Osborn et al., 2003). In leptin receptor deficient 
(db/db) mouse model used in this study, deficiency in leptin signaling causes a dysregulation in 
energy balance leading to obesity characterized by hyperphagia and inslun resitance caused by 
decreased energy expenditure. These metabolic complications in turn were alleviated by NRE 
administration in control (db/db) mice resulting in a decreasing on body weight gain on these 
mice (Fig. 4. 1. and Table 4. 1.). However, the same effect was not observed on lean normal 
mice since they don’t represent a leptin resistance and leptin acts normally as a feedback signal 
reflecting the nutritional status leading to a maintained energy homeostasis (Ahima et al., 1996). 
In current study, main results showed that NRE administration in db/db mice significantly 
increased hepatic lipolytic enzymes expression such as CPT1 (Fig. 4. 6. C1.) and the 
transcriptional activity of PPAR-α (Fig. 4. 4. A1.), having the key role in the induction of fatty 
acid oxidation enzymes. In other side, NRE administration significantly increased lipogenic 
enzymes expression such as FAS and ACC1 (Fig. 4. 5. A1. and B1.) resulting finally in a 
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modulation of lipid metabolism. NRE compounds were reported for their strong antioxidant 
activity in vitro as well as in vivo (Boubaker et al., 2012; Yokozawa et al., 2002). Therefore, the 
enhancement of hepatic lipid metabolism could be attributed also, to the improvement of the 
antioxidant system due to the efficiency of NRE mixture, which in turn increases genes 
expression (FAS and SREBP-1c) that can be damaged by reactive oxygen species production 
within fat cells, that may prevent further lipid storage (Furukawa and Shimomura, 2004). 
However as shown in our results, FAS and SREBP-1c were overexpressed in liver of db/db mice 
treated with NRE which might reflect the enhancement of the hepatic antioxidant status. Taken 
together all results, NRE could attenuate the development of metabolic disorders in transgenic 
diabetic mice due to its enhancement of fatty acid oxidation process and whole the lipid 
metabolism. 
4.5. Conclusion  
The treatment of obesity is difficult and challenging. A large number of scientific works 
indicates that variety crude extracts and isolated components from plants can promote body 
weight loss and prevent metabolic syndrome-related diseases. Indeed, the effects of NRE on 
db/db obese mice model BKS.Cg-Dock7
m
+/+ Lepr
db/
J indicate that Nitraria retusa extract 
mixture possesses potential anti-obesity effects and may relieve obesity-related symptoms 
comprising hyperlipidemia through modulating the lipolysis-lipogenesis balance. Thus NRE 
could be one of possible ways to control obesity and to prevent or reduce the risk of getting 
various obesity-related diseases. 
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Table 4. 1. Body weight gain in db/db mice control, db/db mice NRE, lean mice control and lean 
mice NRE groups after 30 days. 
 
 
          Groups 
                                   Body weight (g) 
Initial Final Cumulative body 
 weight (g) 
db/db mice control 31.00 ± 1.00 42.16 ± 2.56 11.16 ±1.56 
db/db mice NRE 29.00 ± 1.50 34.83 ± 1.75 * 5.83 ± 0.25 * 
Lean mice control 22.50 ± 1.22 23.60 ± 1.71 * 1.10 ± 0.49 * 
Lean mice NRE 22.20 ± 0.75 23.00 ±1.32 * 0.80 ± 0.57 * 
 
 
Data represent the mean ± SD, * p<0.05, when compared to the db/db mice control group. 
db/db mice control: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/db) mice control group. 
db/db mice NRE: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/db) mice treated with ethanolic extract of 
Nitraria retusa (50 mg/kg body weight) group. 
Lean mice control: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/+) mice control group. 
Lean mice NRE: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/+) mice treated with ethanolic extract of 
Nitraria retusa (50 mg/kg body weight) group. 
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Table 4. 2. Food intake (g/week) and (g/day) in in db/db mice control, db/db mice NRE, lean 
mice control and lean mice NRE groups after 30 days. 
   
                Groups 
                                     Total food intake 
                g/week                 g/day 
db/db mice control 42.77 ± 7.59 6.10 ± 0.65 
db/db mice NRE 38.57 ± 5.10 5.50 ± 0.50 
Lean mice control 25.17 ± 3.80 3.59 ± 0.69 
Lean mice NRE 25.87 ± 4.75 3.69 ± 0.85 
 
 
Data represent the mean ± SD, * p<0.05, when compared to the db/db mice control group. 
db/db mice control: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/db) mice control group. 
db/db mice NRE: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/db) mice treated with ethanolic extract of 
Nitraria retusa (50 mg/kg body weight) group. 
Lean mice control: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/+) mice control group. 
Lean mice NRE: BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/+) mice treated with ethanolic extract of 
Nitraria retusa (50 mg/kg body weight) group. 
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Fig. 4. 1. Effect of daily oral administration of Nitraria retusa ethanolic extract (50 mg/kg body 
weight) on weight gain of BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice. Mice were divided to 4 groups: 2 
groups; db/db mice control and db/db mice NRE; were orally administrated with a daily dose of 
0 and 50 mg/kg of body weight (BW) respectively for 4 weeks. Their two litter mates groups; 
db/
+ 
(lean mice) control and db/+ (lean mice) NRE were also orally administrated with a daily 
dose of 0 and 50 mg/kg of body weight (BW) respectively for 30 days. Body weight was daily 
measured at regular time. Data represent mean ± SD, n=8, * p<0.05 compared to db/db mice 
control group. 
 
 
 
 
 
db/db mice control db/db mice NRE 
Lean mice control Lean mice NRE 
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Fig. 4. 2. Effect of daily oral administration of Nitraria retusa ethanolic extract (50 mg/kg body 
weight) on adipose tissue weight of BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice; Mice were divided to 4 
groups: 2 groups; db/db mice control and db/db mice NRE; were orally administrated with a 
daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 4 weeks. Their two litter 
mates groups; db/
+ 
(lean mice) control and db/+ (lean mice) NRE were also orally administrated 
with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 30 days. Data of 
db/db mice are shown on (A) and data of lean mice results are shown in (B). At the end of 
experiment, adipose tissue, for all groups, was weighed. Data represent mean ± SEM, n=8, * 
p<0.05, compared to db/db mice control group. 
* 
db/db mice control db/db mice NRE 
Lean mice control Lean mice NRE 
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* 
db/db mice control db/db mice NRE Lean mice NRE Lean mice control 
db/db mice control 
db/db mice control 
db/db mice NRE Lean mice control 
Lean mice control 
Lean mice NRE Lean mice NRE 
Lean mice NRE 
db/db mice NRE 
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Fig. 4. 3. Effect of daily oral administration of Nitraria retusa ethanolic extract (50 mg/kg body 
weight) on blood constituents; Total cholesterol (A; A1, A2), LDL-cholesterol (B; B1, B2), 
HDL-cholesterol (C; C1, C2), Triglycerides (D; D1, D2) and Glucose (E; E1, E2); of BKS.Cg-
Dock7
m
+/+ Lepr
db/
J mice. Mice were divided to 4 groups: 2 groups; db/db mice control and 
db/db mice NRE; were orally administrated with a daily dose of 0 and 50 mg/kg of body weight 
(BW) respectively for 4 weeks. Their two litter mates groups; db/
+ 
(lean mice) control and db/+ 
(lean mice) NRE were also orally administrated with a daily dose of 0 and 50 mg/kg of body 
weight (BW) respectively for 4 weeks. At the end of experiment, blood samples were collected 
and analyzed. Data represent mean ± SEM, n=8, * p<0.05, compared to db/db mice control 
group. 
 
 
* 
db/db mice NRE 
db/db mice NRE 
db/db mice control 
db/db mice control 
Lean mice control 
Lean mice control 
Lean mice NRE 
Lean mice NRE 
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Fig. 4. 4. Effect of daily oral administration of Nitraria retusa ethanolic extract (50 mg/kg body 
weight) on genes regulating lipid metabolism in liver of BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice. Mice 
were divided to 4 groups: 2 groups; db/db mice control and db/db mice NRE; were orally 
administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 4 
weeks. Their two litter mates groups; db/+
 
(lean mice) control and db/+ (lean mice) NRE were 
also orally administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively 
for 4 weeks. At the end of experiment, liver samples were collected and analyzed. Peroxisome 
proliferator activated receptor alpha; PPAR-α; (A; A1, A2) and Peroxisome proliferator activated 
receptor gamma; PPAR-γ1; (B; B1, B2). Real time PCR was conducted and result was 
represented as m RNA expression fold change compared to the db/db mice control group and 
lean mice control group. Bars represent mean ± SD, n=3,* p<0.05, ** p<0.01 compared to db/db 
mice control group 
** 
* 
PPAR-γ1 PPAR-γ1 
PPAR-α PPAR-α 
Lean mice NRE 
Lean mice NRE 
Lean mice control 
Lean mice control 
db/db mice NRE 
db/db mice NRE 
db/db mice control 
db/db mice control 
98 
 
 
A1                                                                                     A2 
 
 
 
 
 
 
B1                                                                                  B2 
 
 
 
 
 
 
 
Fig. 4. 5. Effect of daily oral administration of Nitraria retusa ethanolic extract (50 mg/kg body 
weight) on genes regulating lipid metabolism in liver of BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice. Mice 
were divided to 4 groups: 2 groups; db/db mice control and db/db mice NRE; were orally 
administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 30 days. 
Their two litter mates groups; db/+
 
(lean mice) control and db/+ (lean mice) NRE were also 
orally administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 4 
weeks. At the end of experiment, liver samples were collected and analyzed. Fatty acid synthase; 
FAS; (A; A1, A2), and Acetyl-CoA-Carboxylase; ACC1; (B; B1, B2). Real time PCR was 
conducted and result was represented as m RNA expression fold change compared to the db/db 
mice control group and lean mice control group. Bars represent mean ± SD, n=3, ** p<0.01 
compared to db/db mice control group. 
** 
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Fig. 4. 6. Effect of daily oral administration of Nitraria retusa ethanolic extract (50 mg/kg body 
weight) on genes regulating lipid metabolism in liver of BKS.Cg-Dock7
m
+/+ Lepr
db/
J mice. Mice 
were divided to 4 groups: 2 groups; db/db mice control and db/db mice NRE; were orally 
administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 30 days. 
Their two litter mates groups; db/+
 
(lean mice) control and db/+ (lean mice) NRE were also 
orally administrated with a daily dose of 0 and 50 mg/kg of body weight (BW) respectively for 4 
weeks. At the end of experiment, liver samples were collected and analyzed. Sterol regulatory 
element-binding protein-1-c: SREBP-1c; (A; A1, A2), Lipoprotein Lipase: LPL; (B; B1, B2) and 
Carnitine palmitoyltransferase I; CPT1; (C; C1, C2). Real time PCR was conducted and result 
was represented as m RNA expression fold change compared to the db/db mice control group 
and lean mice control group. Bars represent mean ± SD, n=3, ** p<0.01 compared to db/db mice 
control group. 
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                                           CHAPTER 5 
 
 
Identification of main phenolic compounds of Nitraria retusa 
extracts (stem, leaf, and their mixture) and evaluation of their 
anti-adipogenic activity in 3T3-L1 cell line 
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5.1. Introduction 
 
The plant kingdom has become a target for the search by multinational drug companies and 
research institutes for new drugs and biologically active lead compounds (Li and Vederas, 2009). 
The world health organization (WHO) reported in 2002 that the herbal medicine serve the health 
need of about 80% of the world’s population, especially for millions of people in the vast rural 
areas of developing countries (Soltan et al., 2009). As known actually, phenolic compounds are 
receiving increasing attention because of their health promoting effect, attributed to their various 
biological activities and strong capacity to improve food quality and stability (Burn and Kishore, 
2000). Phenolic compounds represent the most studied phytochemicals and have been widely 
exploited as model systems in different areas of plant research such as pharmaceutical, food, 
cosmetic and chemical industries (Boudet, 2007). Improving knowledge on the use of anti-obesity 
medicinal preparations, and encouraging obese patients to consume them along with a healthy diet 
should be continued (Kazemipoor et al., 2012). In order to use safely, the medicinal plants in 
controlling and treating obesity, further chemical, biological, and clinical studies are needed on the 
efficiency of selected plants. Plant extracts may be the whole plant, or plant organs (stem, leaf, 
flowers, and roots). Several investigations should focus on the difference between the combination 
and the single effect of such compounds. In view of the diversity and the structural complexity of 
these bioactive molecules, their extraction is influenced by several parameters and technology 
including the nature, polarity, the extracting power of the solvent, and extraction method (Luthria, 
2007). High performance liquid chromatography (HPLC) is the method of choice for the analysis 
of phenolic compounds, because of its versatility, precision and relatively low cost (Parejo et al., 
2004). Most frequently, reversed-phase (RP) C18 columns, a binary solvent system containing 
acidified water and polar organic solvent (acetonitrile or methanol) and UV-Vis diode array 
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detection (DAD) are used and so far to constitute a crucial and reliable tool in the routine analysis 
of plant phenolic compounds (Naczk and shahidi, 2004). 
The aim of this chapter is to analyze the phenolic composition of three extracts of Nitraria retusa 
plant; stem extract, leaf extract and whole aerial part extract (mixture of leaves and stems in equal 
quantity of dried matter). In a further step, we aim to test the anti-adipogenic effect on 3T3-L1 
cells of organ extracts (stems, leaves) as well as some determined phenolic compounds of Nitraria 
retusa. This is in order to compare the efficiency and safety of combined effect (stem extract, leaf 
extract or their mixture extract) and single effect (single phenolic compounds). 
 
5.2. Material s and Methods 
5.2.1. Chemical analyses of the general composition of Nitraria retusa extract using reverse 
phase- high performance liquid chromatography (RP-HPLC) 
 
During this experiment, the same extract of Nitraria retusa used previously was kept. Before 
injection into the HPLC system, extract was passed through a 0.45 μm nylon filter. The 
separation of selected phenolic compounds was carried out using HPLC system (consisting of a 
vacuum degasser, an autosampler, and a binary pump with a maximum pressure of 600 bar; 
Agilent 1260, Agilent technologies, Germany) equipped with a reversed phase C18 analytical 
column of 4.6 x 100 mm and 3.5μm particle size (Zorbax Eclipse XDB C18). Column 
temperature was maintained at 25°C. The injected sample volume was 2 μL and the flow-rate of 
mobile phase was 0.4 mL/min. Mobile phase B was milli-Q water consisted of 0.1% formic acid 
and mobile phase A was methanol. The optimized chromatographic condition was revealed as 
follows: 10% A, 90% B (0 min); 20% A, 80% B (5 min); 30% A, 70% B (10 min); 50% A, 50% 
B (15 min); 70% A, 30% B (20 min); 90% A, 10% B (25 min); 50% A, 50% B (30 min); 10% 
104 
 
A,90% B (35 min). UV-vis absorption spectra were recorded online during the HPLC analysis. 
The DAD detector was set to a scanning range of 200-400 nm. Peak identification was obtained 
comparing the retention time and the UV-vis spectra of Nitraria retusa phenolics chromatogram 
with those of available standards (Guyot et al., 1998). Quantification was performed by reporting 
the measured integration area in the qualibration equation of the corresponding standard. 
 
5.2.2. Cell culture 
Murine 3T3-L1 preadipocytes (Riken Tsukuba japan) were maintained in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin 
(5000 μg/mL)-streptomycin (5000 IU/mL) in 75-cm2 tissue culture flasks. Medium was changed 
every 3 days and cell passage was carried out at 80% confluence at one on two ratio using 0.25% 
trypsin (1 mM EDTA). 3T3-L1 cells were cultured in a humidified incubator at 37°C and 5% 
CO2. 
5.2.3. Pre-adipocytes differentiation and oil-Red-O staining procedures 
3T3-L1 pre-adipocytes were seeded into 96-well plates at 1.0 x 10
4
 cells/well, and cultured for 
additional two days until full confluence. Two days later (Day 0), cells were incubated with a 
differentiation cocktail (MDI) containing 1/10 insulin solution, 1/10 dexamethasone solution and 
1/10 3-isobutyl-1-methylxanthine solution in standard culture medium for 3 days followed by 
additional 48 h with standard culture medium containing insulin alone. The differentiation-
maintenance medium was changed every 2 days. To investigate the effect Nitraria retusa stem 
and leaf extracts on adipogenesis in 3T3-L1, at different doses; (25, 50, 100, 200 and 400 
μg/mL) were added to the differentiation-induction and differentiation-maintenance media. The 
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same procedure was conducted to investigate the effect of the determined phenolic compounds 
of NR; Luteolin-7-O-glucoside (5, 25, 50, 100 and 200 μM), Isorhamnetin (5, 25, 50, 100 and 
200 μM) and Isorhamnetin-3-O-rutinoside (5, 25, 50, 100 and 200 μM). The staining procedure 
was conducted according to the adipogensis assay kit (Cayman chemical company). The 
absorbance was read at 490 nm with a 96-well plate reader. The lipid droplet content was 
reported as percentage of control cells. 
5.2.4. Cell proliferation assay (MTT assay) 
Cell proliferation was investigated by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay. 3T3-L1 cells were seeded in 96-well plates at 1 × 10
5
 
cells/mL. After incubation for 7 days (adipocytes), leaf and stem exracts samples diluted in 
medium were added at final concentrations of 25, 50, 100, 200, 400 μg/mL. The same procedure 
was conducted to investigate the effect of the determined phenolic compounds of NR; Luteolin-
7-O-glucoside (5, 25, 50, 100 and 200 μM), Isorhamnetin (5, 25, 50, 100 and 200 μM) and 
Isorhamnetin-3-O-rutinoside (5, 25, 50, 100 and 200 μM). MTT was added after treatment for 7 
days, and the resulting formazan was completely dissolved by 100 μL of 10% sodium dodecyl 
sulfate (SDS) for 24 h. The absorbance was determined at 570 nm in a multi-detection 
microplate reader (Power-scan HT, Dainippon Pharmaceutical, NJ, USA). Absorbance caused by 
the ability of the sample to reduce MTT or by its color, was corrected using plates as blanks, 
prepared in the same conditions in the absence of cells.   
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5.3. Results 
5.3.1. Chemical analyses of the general composition of Nitraria retusa extracts using reverse 
phase- high performance liquid chromatography (RP-HPLC) 
 
Based on the HPLC analysis, the chromatographic profiles of Nitraria retusa extracts: stem part 
extract, leaf part extract and, mixed (leaf and stem) part extract acquired at 254 nm were 
presented in Fig. 5. 1., Fig. 5. 2., Fig. 5. 3., respectively. Nine main components were identified 
in the leaf part extract (Table 5. 1.). Nine main components were identified in the stem part 
extract (Table 5. 2.). Ten main components were identified and quantified in the mixed (leaf and 
stem) part extract (Table 5. 3.). Peak identification was obtained comparing the retention time 
and the UV spectra of Nitraria retusa phenolics chromatogram with those of available standards 
(Guyot et al., 1998). Quantification was performed by reporting the measured integration area in 
the qualibration equation of the corresponding standard. The retention time of available 
standards used were presented in (Table 5. 4.). Three main flavonoids were common in the three 
different extracts; isorhamnetin, isorhamnetin-3-O-rutinoside and luteolin-7-O-glucoside and 
having different chemical structure. According to quantification measurements, the 
concentrations in stem extract (µg/mL) of isorhamnetin, isorhamnetin-3-O-rutinoside and 
luteolin-7-O-glucoside were: 1.463; 130.417; and 7.902; respectively (Table 5. 1.). Concerning, 
the concentrations in leaf extract (µg/mL) of isorhamnetin, isorhamnetin-3-O-rutinoside and 
luteolin-7-O-glucoside were: 0.539; 278.010; 252.403; respectively (Table 5. 2.). In mixed part 
extract, the concentrations (µg/mL) of isorhamnetin, isorhamnetin-3-O-rutinoside and luteolin-7-
O-glucoside were: 1.141; 396.508; 198.340; respectively (Table 5. 3.). These Flavonoids were 
choosen for further experiments to test the single effects of Nitraria retusa components on cell 
viability, differentiation and lipid droplet formation in 3T3-L1 cells. 
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5.3.2. Effect of Nitraria retusa extracts and single bioactive components on cell 
differentiation and lipid droplet formation in 3T3-L1 cells 
Adipogenesis assay was performed to investigate the effect of Nitraria retusa extracts (stem part 
extract, leaf part extract), as well as the effect of chosen bioactive components (isorhamnetin, 
isorhamnetin-3-O-rutinoside and luteolin-7-O-glucoside) on the adipocyte differentiation and on 
the lipid droplets accumulation in 3T3-L1 cells. Differentiated 3T3-L1 cells were treated every 
two days with the different extracts described above, at various concentrations (25, 50, 100, 200 
and 400 μg/mL), for 7 days. In another hand, in order to compare the effect of single compounds 
to the combined effect, differentiated 3T3-L1 cells were treated every two days with various 
concentartions of selected chemical compounds (5, 25, 50, 100 and 200 μM). Based on Oil-red-
O content quantification, results showed that Nitraria retusa extracts (stem extract and leaf 
extract) treatments at 25, 50, 100, 200 and 400 μg/mL, in 3T3-L1 cells could not inhibit the lipid 
droplet accumulation compared to untreated cells, in dose dependent manner (Fig. 5. 4. A., B.). 
However their combined extract (stem and leaf) used in in previous chapters, and as shown in 
chapter 2, could exhibit stronger inhibition effect on adipogenesis (Fig. 2. 1. A.). Regarding the 
effect of chemical compounds identified in Nitraria retusa extracts on adipogensis, results 
showed that dependent on the chemical structure and molecular weights of all compounds tested, 
there is a variability of their effect on 3T3-L1 differentiation and triglyceride accumulation 
within cells (Fig. 5. 5.). Actually, isorhamnetin showed the strongest effect for all tested doses 
even for the lowest one (5 μM), compared to the other flavonoids glycosides (isorhamnetin-3-O-
rutinoside and luteolin-7-O-glucoside). After treating cells with isorhamnetin in various doses (5, 
25, 50, 100, 200 μM), the triglyceride accumulation significantly decreased to 24.45 ±2.90%, 
24.45 ±2.40%, 28.33 ±3.22%, 31.31 ±3.15%, and 20.57 ±0.62% respectively (Fig. 5. 5. C.).  
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However, high doses of isorhamnetin-3-O-rutinoside and luteolin-7-O-glucoside (50, 100, 200 
μM) exhibited a significant reduction of lipid accumulation (Fig. 5. 5. A., B.), accompanied with 
cell morphological changes based on microscopic observation. Therefore, it is necessary to 
correlate the obtained results with the MTT assay results in next section. 
5.3.3. Effect of Nitraria retusa extracts and single bioactive components on cell viability of 
3T3-L1 cells 
Observation of the cell morphological changes of 3T3-L1 adipocytes after treatment with 
Nitraria retusa extract (leaf part extract), in various concentrations (25, 50, 100, 200 and 400 
μg/mL) revealed no significant decrease in cell viability for all tested doses (Fig. 5. 6. A.). 
However, stem extract treatments (25, 50, 100, 200 and 400 μg/mL) showed a slight significant 
decrease in cell viability about 20 and 30% for 100, 200 and 400 μg/mL doses (Fig. 5. 6. B.). 
Concerning the single chemical bioactive compounds tested, cell viability was slightly 
significant affected by isorhamnetin-3-O-rutinoside treatments (25, 50, 100, 200 μM) with just 
5% maximum of cell viability reduction for the higher dose (Fig. 5. 7. A.). Luteolin-7-O-
glucoside treatments affected more significanly the cell viability by decreasing it by a maximum 
around 30% for the higher dose (200 μM) (Fig. 5. 7. B.). Nonetheless, isoramnetin strongly 
affected the 3T3-L1viability by 30% and 60% reduction for 100 and 200 μM, respectively (Fig. 
5. 7. C.). 
5.4. Discussion 
Nitraria retusa extracts (stem, leaf) exhibited a lower anti-adipogenic activity compared to their 
single constituents (isorhamnetin, isorhamnetin-3-O-rutinoside, and luteolin-7-O-glucoside). 
This could be explained by the antagonistic effects of some compounds present in NR, and also 
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that these pure compounds tested in different doses (5, 25, 50, 100, 200 μM) were diluted in the 
original ethanolic extracts (stem, leaf) (Ling et al., 2010). In another hand, the biological activity 
could be attributed to the chemical structure of each compound, such as the presence of methoxyl 
group on the ring B of isorhamnetin-3-O-robinobioside that could participate in the antioxidant 
potential of this molecule (Boubaker et al., 2012). It has been also reported that several 
flavonoids with methoxyl substitutions exhibited higher anti-cancer activities (Boubaker et al., 
2011). In our study, isorhamnetin was more effective compared to the other compounds 
(isorhamnetin-3-O-rutinoside, luteolin-7-O-glucoside) even in the lowest dose (5 μM). 
Moreover, this compound is present in low quantity in different NR extracts based on the RP-
HPLC analysis. The strong activity of isorhamnetin could be due to the contribution of its 
chemical structure since it is the only compound of NR extracts possessing a methoxy group at a 
3-position and glucose free. In this context, it was reported that flavonoids with methoxy groups 
showed stronger anti-diabetic effects particularly those with a methoxy group at the 3-position 
(Matsuda et al., 2011). As well, it was reported in comparison study between isorhamnetin free 
and isorhamnetin diglucoside on their anti-oxidant activities in vivo system that isorhamnetin 
diglucoside is metabolized in vivo by intestinal bacteria to isorhamnetin and that isorhamnetin 
plays an important role as anti-oxidant having a greater biological effect (Yokozawa et al., 
2002). Thus, some previous studies confirmed that biological activity depends on the presence or 
absence of the glycoside residue (Hadj Salem et al., 2011; Williamson et al., 1996). However, in 
addition to the efficiency parameter, safety of tested doses of different compounds should be 
considered. Isorhamnetin in single effect showed a reduction on cell viability of 3T3-L1 cells 
compared to other glycosides compounds (Fig. 5. 7.). Generally, the composition of crude 
extract will depend on the solvent used and also on the quality of the original material, and its 
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composition (Jallali et al., 2012). In order to obtain a high quality extract with antioxidant 
activity that is suitable for use in the food, cosmetic, and pharmaceutical industries, the extract 
must be purified to remove all inert and undesirable components, so as to improve the 
antioxidant and biological activity of the bioactive molecules. A purification and fractionation 
processes that remove fractions with limited antioxidant activity might enable a good level of 
biological activity to be obtained from relatively small amounts of the original natural extract 
(Barbosa-Pereira et al., 2013). Thus, fractionation, purification, and/or the isolation of active 
principle(s) could increase bioactive component bioavailability in the extracts, and improve 
medicinal agent efficacy in weight loss (Sheng et al., 2008; Calixto et al., 2000). In this way, 
isolation of components inhibiting the anti-obesity compounds would be necessary. Further 
studies should be continued to purify phenolics from natural (and possibly safer) alternative 
sources of antioxidants. Because of their benefits to human health, natural antioxidants isolated 
from Nitraria retusa could be an alternative used in food industries in order to avoid or at least 
reduce the use of synthetic products. 
5.5. Conclusion 
As far the Nitraria retusa extracts (stem extract, leaf extract, mixed leaf and stem extract) tested 
in the current study were in crude form and probably contained many bioactive components 
which may well act in synergy. It is not possible to determine which compounds are responsible 
for the observed effects. However, our data suggest that the biological effects exhibited by this 
plant, under determined experimental conditions described throughout the dissertation, could be 
related to an overall effect of bioactive molecules extracted by 70 % ethanol. 
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Table 5. 1. Identification and quantification of phenolic compounds of stem extract of Nitraria 
retusa. 
 
 
 
Table 5. 2. Identification and quantification of phenolic compounds of leaf extract of Nitraria 
retusa. 
N°Peak Retention Time 
(min) 
Area Identification Quantification 
 (µg/mL) 
1 10.813 27.2 Resorcinol 69.152 
2 15.685 150 Chlorogenic acid 20.690 
3 20.220 66.6 Sinapic acid 9.651 
4 21.191 2539.3 Luteolin 7-O-glucoside 252.403 
5 21.756 23.5 Isoquercitrin 16.708 
6 21.866 158.5 Hyperoside 6.388 
7 22.839 1523.1 Isorhamnetin 3-O- rutinoside 278.010 
8 24.473 23.9 Quercetin 1.828 
9 25.840 11.9 Isorhamnetin 0.539 
 
 
 
 
 
 
 
 
N°Peak Retention Time 
(min) 
Area Identification Quantification 
(µg/mL) 
1 10.882 30.5 Resorcinol 77.542 
2 15.882 43.2 Chlorogenic acid 25.958 
3 20.010 13.7 P-coumaric acid 3.335 
4 20.306 30.1 Sinapic acid 4.361 
5 21.179 79.5 Luteolin 7-O-glucoside 7.902 
6 21.875 63 Hyperoside 2.539 
7 22.804 714.5 Isorhamnetin 3-O- rutinoside 130.417 
8 24.559 23.6 Quercetin 1.805 
9 25.840 32.3 Isorhamnetin 1.463 
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Table 5. 3. Identification and quantification of phenolic compounds of mixed part extract of 
Nitraria retusa 
 
 
Table 5. 4. List of standards and their retention time (min). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N °Peak Retention time 
(min) 
Area Identification Quantification 
(µg/mL) 
1 10.878 31.4 Resorcinol 79.830 
2 15.769 169.1 Chlorogenic acid 23.325 
3 20.038 29.6 P-coumaric acid 7.207 
4 20.248 113.8 Sinapic acid 16.491 
5 21.219 1995.4 Luteolin-7-O-glucoside 198.340 
6 21.772 374 isoquercitrin 265.921 
7 21.888 184.7 Hyperoside 7.444 
8 22.861 2172.3 Isorhamnetin 3-O rutinoside 396.508 
9 24.595 66.2 Quercetin 5.065 
10 25.887 25.2 Isorhamnetin 1.141 
 
Standards 
 
Retention time (min) 
Resorcinol 10.835 
Chlorogenic acid  15.918 
P-coumaric acid 20.091 
Sinapic acid  20.278 
Luteolin-7-O-glucoside 21.145 
Isoquercetin 21.745 
Hyperoside 21.803 
Isorhamnetin-3-O-rutinoside 22.986 
Quercetin 24.285 
Isorhamnetin 25.899 
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Fig. 5. 1. Chromatographic profile of stem part extract of Nitraria retusa acquired at 254 nm. 
      Peaks were identified based on the retention time of standards. 1: Resorcinol, 2: Chlorogenic 
acid, 3: P-coumaric acid, 4: Sinapic acid, 5: Luteolin 7-O-glucoside, 6: Hyperoside, 7: 
Isorhamnetin 3-O- rutinoside, 8: Quercetin, 9: Isorhamnetin. 
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Fig. 5. 2. Chromatographic profile of leaf part extract of Nitraria retusa acquired at 245 nm. 
Peaks were identified based on the retention time of standards. 1: Resorcinol, 2: Chlorogenic 
acid, 3: Sinapic acid, 4: Luteolin 7-O-glucoside, 5: Isoquercitrin, 6: Hyperoside, 7: Isorhamnetin 
3-O- rutinoside, 8: Quercetin, 9: Isorhamnetin. 
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Fig. 5. 3. Chromatographic profile of mixed part extract (leaf and stem) of Nitraria retusa 
acquired at 245 nm.  
Peaks were identified based on the retention time of standards. 1: Resorcinol, 2: Chlorogenic 
acid, 3: P-coumaric acid, 4: Sinapic acid, 5: Luteolin 7-O-glucoside, 6: Isoquercitrin, 7: 
Hyperoside, 8: Isorhamnetin 3-O- rutinoside, 9: Quercetin, 10: Isorhamnetin. 
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Fig. 5. 4. Effects of Nitraria retusa extracts; Leaf extracts (25, 50, 100,200 and 400 μg/mL): (A) 
and Stem extracts (25, 50, 100, 200 and 400 μg/mL): (B) on lipid droplet content in 3T3-L1 cells. 
Lipid droplet accumulation in treated cells was expressed as a percentage of control (untreated 
cells). Fat droplets in adipocytes differentiated for 7 days with or without treatments, were 
stained with oil Red-O dye and relative Oil-Red-O absorbance was measured at 490 nm. Bars 
represent mean ± SD, n=3, ** p<0.01 vs. control. 
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Fig. 5. 5. Effects of luteolin-7-O-glucoside (5, 25, 50, 100 and 200 μM): (A), isorhamnetin-3- O-
rutinoside (5, 25, 50, 100 and 200 μM): (B) and isorhamnetin (5, 25, 50, 100 and 200 μM): (C) 
on lipid droplet content in 3T3-L1 cells. Lipid droplet accumulation in treated cells was 
expressed as a percentage of control (untreated cells). Fat droplets in adipocytes differentiated 
for 7 days with or without treatments, were stained with oil Red-O dye and relative Oil-Red-O 
absorbance was measured at 490 nm. Bars represent mean ± SD, n=3, * p<0.05, ** p<0.01, *** 
p<0.001 vs. control. 
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Fig. 5. 6. Effects of Nitraria retusa extracts; leaf extract (25, 50, 100,200 and 400 μM): (A) and 
stem extract (25, 50, 100, 200 and 400μg/mL): (B) on 3T3-L1 pre-adipocytes viability during 
differentiation (7 days treatments). Bars represent mean ± SD, n=3, * p<0.05. 
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Fig. 5. 7. Effects of luteolin-7-O-glucoside (5, 25, 50, 100 and 200 μM): (A), isorhamnetin-3- O-
rutinoside (5, 25, 50, 100 and 200 μM): (B) and isorhamnetin (5, 25, 50, 100 and 200 μM): (C) 
on 3T3-L1pre-adipocytes viability during differentiation (7 days treatments). Bars represent 
mean ± SD, n=3, * p<0.05, ** p<0.01, *** p<0.001. 
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General conclusion and perspectives 
 
This chapter aims to give a summary of the main findings in this dissertation and to address 
several questions as future perspectives to the application of Nitraria retusa, as a food 
supplement. The medicinal plants can be used in the prevention or treatment of many diseases. 
Several studies concerning the potential of bioactive components in plants and food products and 
their link to obesity and related metabolic disorders, have been gaining big interest. Halophytes, 
salt-tolerant species, are considered a potent source of various chemical secondary metabolites 
since they have the ability to overcome the severe and extreme environmental conditions due to 
their powerful antioxidant system. Mechanisms of anti-obesity actions of medicinal plants have 
been outlined, either by using in vitro or in vivo models. 3T3-L1 is a pre-adipose cell line widely 
used in obesity research. Suppression of pre-adipocyte differentiation or reduction of cell 
viability is considered as possible ways to treat obesity. In the other hand, many in vivo models 
are used for the prevention or treatment of obesity and obesity-related complications, such as 
monogenic mice models and high-fat diet induced-obese mice models. In current study, our main 
first target was first to perform a screening assay of 6 halophytes extracts (Nitraria retusa, 
Tamarix gallica, Mesembryanthemum edule, Atriplex inflata, Arthrophytum scoparium and 
Rhanterirum sueavelons) on basis of their phenolic composition, antioxidant activities and anti-
adipogenic activity in 3T3-L1 cell line model. Adipogenesis assay was performed to investigate 
the effect of halophytes extracts on the adipocyte differentiation and on the lipid droplets 
accumulation in 3T3-L1 cells using Oil red O staining. Differentiated 3T3-L1 cells were treated 
every two days with halophyte samples extracts at various concentration and with 25 μM 
isorhamnetin (as a positive control), for 7 days. Based on Oil-red-O content quantification, 
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results showed that Nitraria retusa ethanolic extract (NRE) treatment at 25, 50, 100, 200 and 400 
μg/mL, could inhibit the lipid droplet accumulation in 3T3-L1 cells compared to untreated cells, 
in dose dependent manner. Compared to other samples, Nitraria retusa extract was shown to 
possess a potential reduction of lipid droplet accumulation within cells, with modulation of 
hypertrophy (cell size) rather than hyperplasia (cell number) and without any cytotoxicity effect 
on cell viability (MTT assay, Via-count assay using flow cytometry). Thus NRE treatment might 
induce the cell differentiation into smaller adipocytes compared to untreated cells. Evaluating 
genes expression related to 3T3-L1 differentiation (CEBP-α, PPAR-γ) and their target genes; 
adipocyte-specific genes; such as FAS, LPL and SREBP-1c, could be appropriate targets for 
preventive intervention against obesity. Nitraria retusa ethanolic extract (NRE), could up-
regulate these genes which is correlated with the induction effect of cell differentiation but in 
smaller adipocytes. Therefore, it reduced the harmful effect of oxidative stress and insulin 
resistance caused by fat accumulation within big adipocytes. Further step was aimed to 
investigate the effect of oral administration NRE in vivo, using high-fat diet-induced C57B6J/L 
obese mice model. Male C57B6J/L mice were separately fed a normal diet (ND) or a high-fat 
diet (HFD) and daily administrated with NRE (50, 100 mg/kg BW) or once 2 days with 
Naringenin (10 mg/kg BW). NRE administration significantly decreased body weight gain, fat-
pad weight, serum glucose, and lipid levels in HFD-induced obese mice. To elucidate the 
mechanism of action of NRE, the expression of genes involved in lipid metabolism were 
measured in liver. Results showed that mice treated with NRE demonstrated a significant 
decreasing in cumulative body weight and fat pad weight, a significant lowering in glucose and 
triglycerides serum levels, as well as an increasing in the HDL-cholesterol serum level. 
Moreover mRNA expression results showed an enhancement of the expression of genes related 
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to hepatic lipid metabolism. Our findings suggest that NRE treatment had a protective or 
controlling effect against a high fat diet-induced obesity in C57B6J/L mice through the 
regulation of expression of genes involved in lipolysis and lipogenesis thus the enhancement of 
the lipid metabolism in liver.  We concluded that NRE administration could control or prevent 
obesity caused by high fat diet intake. In next step and in order to test whether the efficiency of 
this extract could be maintained even in obesity-related metabolic syndrome ‘Diabetes’, we used 
transgenic diabetic obese model mice BKS.Cg-Dock7
m
+/+ Lepr
db/
J (db/db). We orally 
administrated NRE (50mg/kg BW) to BKS.Cg-Dock7m+/+ Leprdb/J mice model for a period of 
30 days. The effect was also evaluated on the body weight and adiposity changes and on the 
biochemical parameters of db/db NRE-treated mice. The molecular mechanism underlying the 
anti-obesity effect was investigated by testing the gene expression related to hepatic lipid 
metabolism. NRE was found to significantly suppress increases in body and fat mass weight, 
decreases triglycerides and LDL-cholesterol levels and enhances gene expression related to lipid 
homeostasis in liver showing anti-obesity actions. Our findings, indicate that NRE possesses 
potential anti-obesity effects in BKS.Cg-Dock7m+/+ Leprdb/J mice model and may relieve 
obesity-related symptoms including hyperlipidemia through modulating the lipolysis-lipogenesis 
balance. As conclusion we observed the same tendency to reduce body weight gain, to regulate 
blood biochemistry as well as to enhance the lipid metabolism in liver of both of mice models 
(C57B6J/L and BKS.Cg-Dock7m+/+ Leprdb/J). Taken together all results, Nitraria retusa 
ethanolic extract could exert anti-obesity actions in vitro and in vivo models. Nitraria retusa 
mixture may relieve obesity and obesity-related symptoms including hyperlipidemia through 
modulating the lipid metabolism balance (lipogenesis-Lypolysis) in liver of both mice models 
studied in this dissertation. Although not bound by theory, the Nitraria retusa extract disclosed 
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herein likely have superior anti-obesity activity which could be due to synergy brought by the 
combination of compounds included in the extract. Nitraria retusa extract used in this research, 
was analyzed by reverse phase- high performance liquid chromatography (RP-HPLC) system. It 
is likely rich in naturally present flavonoids especially glycosides ones such as; luteolin7-O-
glucoside, isorhamnetin-3-O-rutinoside, isorhamnetin, quercetin and others, that could work all 
in synergy. Thus, NRE mixture could be one of possible ways to control obesity and to prevent 
or reduce the risk of getting various obesity-related diseases. 
 In conclusion, reducing body weight in db/db mice and controlling weight gain in 
C57B6J/Lmice fed a high fat diet, without appetite suppression and decreasing fat accumulation 
within cells, as well as enhancement of lipid metabolism of mentioned mice by NRE exposure 
could ameliorate obesity and obesity-related metabolic diseases such as Diabetes. Dietary 
polyphenols may exert their pharmacological effect via synergistic interactions with multiple 
targets. Therefore, further studies would be needed to search for new candidates of molecules or 
their mixture (single and/or mixed effects of some interesting components present in NRE) as 
functional foods for anti-obesity effects. Thus, to study the effects of all possible metabolites 
becomes an enormous and fascinating target, which will be undoubtedly matter for future 
research. However, when polyphenols were fractionated and isolated, the benefits of the whole 
extract were greater than the sum of its parts. In general, polyphenols have interactive and 
complementary effects, which suggest a possible application in the management of complex 
diseases and efforts to isolate individual components might be irrelevant for clinical medicine 
and/or human nutrition. The botanical sources, route of administration, presence of various 
bioactive components and their respective functions, experimental methods used, treatment 
dosage, study design, treatment duration, and safety and efficacy of the plant are also crucial 
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factors. Further chemical, biological, and clinical studies are needed on the effectiveness of 
selected medicinal plants in ameliorating and treating obesity in humans, in order to improve our 
knowledge on the use of anti-obesity medicinal herbal preparations. Fractionation, purification, 
and/or the isolation of active principle(s) could increase bioactive component bioavailability in 
the extracts, and improve medicinal agent efficacy in weight loss (Sheng et al., 2008; Calixto et 
al., 2000). In this way, isolation of components inhibiting the anti-obesity compounds would be 
necessary. Further studies should be continued to purify phenolics from natural (and possibly 
safer) alternative sources of antioxidants. Because of their benefits to human health, natural 
antioxidants isolated from Nitraria retusa could be an alternative used in food industries in order 
to avoid or at least reduce the use of synthetic products. 
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Several studies concerning the potential of bioactive components in plants and food products and 
their link to obesity and related metabolic disorders, have been gaining big interest. Halophytes, 
salt-tolerant species, are considered a potent source of various chemical secondary metabolites 
since they have the ability to overcome the severe and extreme environmental conditions due to 
their powerful antioxidant system. Mechanisms of anti-obesity actions of medicinal plants have 
been outlined, either by using in vitro or in vivo models. 3T3-L1 is a pre-adipose cell line widely 
used in obesity research. Suppression of pre-adipocyte differentiation or reduction of cell 
viability is considered as possible ways to treat obesity. In the other hand, many in vivo models 
are used for the prevention or treatment of obesity and obesity-related complications, such as 
monogenic mice models and high-fat diet induced-obese mice models. In current study, our main 
first target was first to perform a screening assay of 6 halophytes extracts (Nitraria retusa, 
Tamarix gallica, Mesembryanthemum edule, Atriplex inflata, Arthrophytum scoparium and 
Rhanterirum sueavelons) on basis of their phenolic composition, antioxidant activities and anti-
adipogenic activity in 3T3-L1 cell line model. Nitraria retusa ethanolic extract (NRE) treatment 
at 25, 50, 100, 200 and 400 μg/mL could inhibit the lipid droplet accumulation in 3T3-L1 cells 
compared to untreated cells, in dose dependent manner. Further step was aimed to investigate the 
effect of oral administration NRE in vivo, using high-fat diet-induced C57B6J/L obese mice 
model. Male C57B6J/L mice were separately fed a normal diet (ND) or a high-fat diet (HFD) 
and daily administrated with NRE (50, 100 mg/kg BW) or once 2 days with Naringenin 
(10mg/kg BW). NRE administration significantly decreased body weight gain, fat-pad weight, 
serum glucose, and lipid levels in HFD-induced obese mice. To elucidate the mechanism of 
action of NRE, the expression of genes involved in lipid metabolism were measured in liver. 
Results showed that mice treated with NRE demonstrated a significant decreasing in cumulative 
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body weight and fat pad weight, a significant lowering in glucose and triglycerides serum levels, 
as well as an increasing in the HDL-cholesterol serum level. Moreover mRNA expression results 
showed an enhancement of the expression of genes related to hepatic lipid metabolism. Our 
findings suggest that NRE treatment had a protective or controlling effect against a high fat diet-
induced obesity in C57B6J/L mice through the regulation of expression of genes involved in 
lipolysis and lipogenesis thus the enhancement of the lipid metabolism in liver.  We concluded 
that NRE administration could control or prevent obesity caused by high fat diet intake. In next 
step and in order to test whether the efficiency of this extract could be maintained even in 
obesity-related metabolic syndrome ‘Diabetes’, we used transgenic diabetic obese model mice 
BKS.Cg-Dock7m+/+ Leprdb/J (db/db). We orally administrated NRE (50 mg/kg BW) to 
BKS.Cg-Dock7m+/+ Leprdb/J mice model for a period of 4 weeks. The effect was also 
evaluated on the body weight and adiposity changes and on the biochemical parameters of db/db 
NRE-treated mice. The molecular mechanism underlying the anti-obesity effect was investigated 
by testing the gene expression related to hepatic lipid metabolism. NRE was found to 
significantly suppress increases in body and fat mass weight, decreases triglycerides and LDL-
cholesterol levels and enhances gene expression related to lipid homeostasis in liver showing 
anti-obesity actions. Our findings, indicate that NRE possesses potential anti-obesity effects in 
BKS.Cg-Dock7m+/+ Leprdb/J mice model and may relieve obesity-related symptoms including 
hyperlipidemia through modulating the lipolysis-lipogenesis balance. Nitraria retusa extract 
used in this research, was analyzed by reverse phase- high performance liquid chromatography 
(RP-HPLC) system. It is likely rich in naturally present flavonoids especially glycosides ones 
such as; luteolin7-O-glucoside, isorhamnetin-3-O-rutinoside, isorhamnetin, quercetin and others, 
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that could work all in synergy. Thus, NRE mixture could be one of possible ways to control 
obesity and to prevent or reduce the risk of getting various obesity-related diseases. 
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